BIOTECHNICA INTERNATIONAL INC
10-K, 1996-09-27
AGRICULTURAL PRODUCTION-CROPS
Previous: INTERNATIONAL LEASE FINANCE CORP, 424B3, 1996-09-27
Next: BRAUVIN REAL ESTATE FUND LP 3, 8-K, 1996-09-27






                             UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C. 20549 


                              FORM 10-K


            ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                  THE SECURITIES EXCHANGE ACT OF 1934


For the Fiscal Year Ended June 30, 1996       Commission File No.: 0-11854


                    BIOTECHNICA INTERNATIONAL, INC.
          (Exact name of registrant as specified in its charter)


       DELAWARE                                           22-2344703
(State or other jurisdiction of                         (I.R.S. Employer
 incorporation or organization)                          Identification No.)


  4001 WAR MEMORIAL DRIVE                           
      PEORIA, ILLINOIS                                       61614
(Address of principal executive offices)                  (Zip Code)


Registrant's telephone number, including area code:  (309) 681-0300


   SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
                   Common Stock, $.01 par value
                       NASDAQ Stock Market

	Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act 
of 1934 during the preceding 12 months, and (2) has been subject to such 
filing requirements for the past 90 days:

                              Yes  X                    No  __ 
	
	Indicate by check mark if disclosure of delinquent filers pursuant to 
Item 405 of Regulation S-K is not contained herein, and will not be 
contained, to the best of registrant's knowledge, in definitive proxy or 
information statements incorporated by reference in Part III of this Form 
10-K or any amendment to this Form 10-K.  X

	At August 30, 1996, the Company had 115,379,628 shares (not including 
 39,160 treasury shares) of its Common Stock, $.01 par value, issued and 
 outstanding.   

	At August 30, 1996, the aggregate market value of the voting stock held 
 by non-affiliates of the registrant was $7,473,537.


DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Company's definitive proxy statement with respect to its 
1996 Annual Meeting of Shareholders to be held on November 12, 1996: Part 
III.


PART I

ITEM 1.  BUSINESS

The Limagrain Transaction

On October 26, 1993, BioTechnica International, Inc. (the "Registrant", 
which together with its subsidiary is referred to herein as "BioTechnica" 
or the "Company") entered into the Credit Enhancement and Reorganization 
Agreement (the "Limagrain Agreement") with Groupe Limagrain Holding S.A. 
("Limagrain") and Limagrain Genetics Corp. ("LG Corp."), a majority-owned 
subsidiary of Limagrain, which was amended on December 10, 1993.  As a 
result of this agreement, on March 7, 1994, following the Company's Annual 
Meeting of Shareholders (the "1993 Annual Meeting"), Limagrain, through LG 
Corp., obtained voting control of the Company (the "Limagrain Transaction").

In the first phase of the transaction, which was consummated on October 27, 
1993 (the "First Closing"), the Company issued 500,000 shares of its common 
stock, par value $.01 per share (the "Voting Common Stock") to LG Corp. in 
consideration of $5,000 and the guarantee of Limagrain and LG Corp. of a $15 
million line of credit arrangement (the "Line of Credit") with its principal 
bank.

In the second phase of the transaction, which was completed following the 
1993 Annual Meeting (the "Second Closing"), the Company issued an additional 
97,777,178 shares of Voting Common Stock to LG Corp. in exchange for the 
transfer to the Company by LG Corp. of all the issued and outstanding shares 
of capital stock of Shissler Seed Company, Inc. ("Shissler"), which held the 
pre-existing United States seed corn production and sales operations of 
Limagrain.  Upon completion of the second phase, Limagrain, through LG 
Corp., obtained approximately 80% of the outstanding capital stock (voting 
and non-voting) and approximately 93% of the outstanding voting common stock 
of BioTechnica.

The exchange of shares described above has been accounted for as a purchase 
of the Company by Shissler (a "reverse acquisition") because Shissler's 
parent, LG Corp., owned 80% of the combined entity after the exchange. See 
"BASIS OF PRESENTATION" below.  After the reverse acquisition, the Company 
adopted a June 30 fiscal year to conform to LG Corp.'s and Shissler's fiscal 
year.

Basis Of Presentation

The consolidated financial statements presented herein reflect the results 
of the reverse acquisition as described above.

For the year ended June 30, 1996 ("Fiscal 1996"), the financial statements 
contained herein present twelve months of operations of the Company.

For the year ended June 30, 1995 ("Fiscal 1995"), the financial statements 
contained herein present twelve months of operations of the Company.  
Results for the Scott Seed Division of the Company and other properties sold 
during Fiscal 1995 are included up to the date of their respective 
disposals.

For the year ended June 30, 1994 ("Fiscal 1994"), the financial statements 
contained herein present twelve months of operations of Shissler, plus 
operations of the Company (as it was constituted prior to the Limagrain 
Transaction) from February 1, 1994 (the effective date of the Limagrain 
Transaction) through June 30, 1994.

Proforma statements have been prepared and are included in the Management 
Discussion and Analysis section that compare full twelve-month operating 
cycles for the Company as it exists today.  In the Proforma Statement, the 
results of the Scott Seed Division and other sold properties have been 
eliminated and costs specifically identified with the Limagrain Transaction 
are not included.

Capital And Financing Activity

On June 29, 1994, BioTechnica, Limagrain, LG Corp. and Shissler entered into 
a Debt Restructuring Agreement (the "Debt Restructuring Agreement") whereby 
(i) certain advances to BioTechnica and Shissler by LG Corp. and Limagrain 
of $8,260,000 in the aggregate were consolidated, (ii) indebtedness in the 
principal amount of $5,000,000 was contributed to the Company as 
consideration for the issuance to LG Corp. of 500,000 shares of a then-
newly-created Class A Preferred Stock, par value $.01 per share, and (iii) a 
new promissory note was issued to LG Corp. in the principal amount of 
$3,261,000.  Pursuant to the Certificate of Designations filed with the 
Secretary of State of Delaware on June 29, 1994, the Class A Preferred Stock 
issued to LG Corp. (i) has no voting rights, (ii) is non-convertible, (iii) 
is redeemable solely at the option of the Company, and (iv) has the right to 
a cumulative dividend at the rate of $0.75 per share per year.

In August 1994, LG Corp. advanced $4,000,000 to the Company as a short-term 
loan to enable the Company to reduce the amounts borrowed under its bank 
line of credit (the "Line of Credit") so as to bring the Company within the 
borrowing base limits of the Line of Credit. 

On November 30, 1994, LG Corp. converted the $4,000,000 advanced to the 
Company into (i) a long-term note for $2,000,000 bearing interest at the 
London Inter-Bank Offered Rate ("LIBOR") plus 1.15%, and (ii) 200,000 shares 
of Class A Preferred Stock of the Company, as described above.  

On November 30, 1994, State Farm Automobile Insurance Company ("State Farm") 
converted 4,698,336 shares of Class A common stock and 4,807,533 shares of 
Class B common Stock of the Company into 9,505,869 shares of common stock of 
the Company.  This conversion was available to State Farm at their option 
under the terms and conditions of the Class A and Class B common stock.  
This transaction had no effect on the net outstanding, fully diluted shares 
of the Company, or on the relative equity of any shareholder.

On June 26, 1995, State Farm sold 6,054,751 shares of Class A common stock 
back to the Company at par value (i.e., $0.01 per share).  This transaction 
represented approximately 5% of the outstanding shares of the Company.  The 
price of $0.01 was substantially below the current market price and the net 
book value per share.  The result of this transaction was to increase the 
equity position of all remaining shareholders by approximately 5%.

On November 30, 1995, the Company converted the $2,000,000 long-term note 
owed to LG Corp. into an additional 200,000 shares of Class A Preferred 
Stock.

Business Restructuring And Redirection

The Company conducts its operations through its operating subsidiary, LG 
Seeds, Inc.  Since the date of the Limagrain Transaction, certain functions 
have been consolidated by combining management and operations into three 
main departments:  (i) administration and finance; (ii) production and 
logistics; and (iii) sales and marketing.  The goal of this restructuring 
has been to streamline operations, eliminate duplicated efforts, improve 
information flow, and  increase efficiency, all with the ultimate goal of 
improving the profitability of the Company.  Under the new structure, the 
Company operates from a corporate headquarters office in Peoria, Illinois, 
produces seed at four locations, and services its customers from seven 
regional service centers.

During Fiscal 1994, as part of this restructuring, the Company sold certain 
of the assets of Donley Seed Company ("Donley"), a forage mix and bird feed 
company.  The operations of Donley did not contribute to the refocused 
corporate strategy of marketing corn and soybean seeds through a dealer 
network located in the Corn Belt Region of the United States.

During Fiscal 1994, the Company changed the name of its largest operating 
division from BioTechnica Agriculture, Inc. to LG Seeds, Inc.  The LG brand 
name is prominent in the introduction of new products throughout the 
Company.

During Fiscal 1995, the Company sold certain unused and unneeded facilities. 
These assets  included:

1.  the unused conditioning plant/warehouse located in Hereford, Texas;
2.  the unused conditioning plant/warehouse located in Manilla, Iowa; and
3.  the unused conditioning plant/warehouse located in Dieterich, Illinois.

Also during Fiscal 1995, the Company sold its Scott Seed Division of New 
Albany, Indiana ("Scott Seed") to AgriBioTech, Inc. ("ABT") for an aggregate 
net purchase price of approximately $1,950,000.  This amount consisted of 
cash, 158,000 shares of ABT common stock with a guaranteed value of 
$3.00 per share, and assumption of the accounts payable of Scott Seed by 
ABT.  Scott Seed markets alfalfa, clover, pasture mixes, and grasses 
throughout Kentucky and Southern Indiana in a wholesale environment.  The 
operations of Scott Seed did not contribute to the refocused corporate 
strategy of marketing corn and soybean seeds through a dealer network 
located in the Corn Belt Region of the United States.  The ABT stock , which 
is traded on the NASDAQ Small-Cap Market was sold during Fiscal 1996 for a 
gain of approximately $94,000, relative to the guaranteed amount, and is 
included as other income (expense).




Continuing Business

The primary business of the Company, a Delaware corporation formed in 1981, 
is the production, processing and sale of agricultural seeds.  Corn, 
soybeans and alfalfa comprise the Company's major product lines.  During 
Fiscal 1996, sales of corn, soybeans, and alfalfa products represented 60%, 
31%, and 4% of net sales, respectively.  This compares to 52%, 26% and 6% of 
the Company's net sales during Fiscal 1995, and 52%, 27% and 7% of the net 
sales for corn, soybeans and alfalfa in Fiscal 1994.  Total net sales for 
Fiscal 1995 and Fiscal 1994 included Scott Seed sales of 14% and 11%, 
respectively, which were primarily grass and other seeds.

The Company contracts with independent farmer-growers for the production of 
corn, soybeans, and wheat to be grown under Company supervision to meet 
specific quality and marketability specifications.  The Company then 
processes and treats the delivered seed with appropriate fungicides and 
insecticides and bags the products for sale.  Because weather conditions can 
cause material fluctuations in yields and seed quality, the Company's cost 
of goods sold is highly dependent upon weather conditions in its growing 
areas.  The Company buys alfalfa and other seed products as finished goods 
from seed producers based upon annually negotiated terms which fluctuate 
with growing conditions and supply levels.

The Company sells its products throughout the midwestern United States 
mainly to farmer-dealers who in turn market the seed to farmers.  Because of 
the seasonal nature of the agricultural seed business, the Company's sales 
are highly concentrated during the period beginning in December and running 
through the spring planting season of each year.  This heavy sales season is 
followed by a period during which the dealers are generally allowed to 
return unplanted seed to the Company.  Reserves are made throughout the 
selling season in anticipation of these returns.  The Company issues 
settlement statements to its dealers following the return period each year 
and generally collects payments on annual sales during the summer or at 
harvest time in the fall, although some payments are received at various 
times throughout the year as induced by early payment discounts.  Management 
believes these practices and policies are typical of those of competitors in 
the seed industry.

Seed product revenues were $18,767,000 for Fiscal 1996, including $1,489,000 
in sales to affiliated companies, primarily in Europe.  These sales to 
affiliated companies are the result of yearly production contracts for 
specific corn varieties and are negotiated at arm's length prior to planting 
season each year.  Total Export sales represent approximately 9% of revenues
for Fiscal 1996 and 15% of revenues for Fiscal 1995.  As a percentage of 
revenues for Fiscal 1994, export sales accounted for 6% of revenues, most of 
which were sales made to affiliate companies.  Sales to affiliated companies 
are based solely on their respective needs.  There is no assurance that 
these levels of sales will be maintained in the future.

Government Regulation 

The Company's business is subject to Federal, state and local regulations.  
The Company is not aware of any material administrative, regulatory or 
judicial actions, suits, demand letters, liens, notices of non-compliance or 
violations, investigations or proceedings which will materially impact the 
Company.

Competition

The Company markets its products primarily in the Corn Belt Region of the 
United States, comprised of approximately 12 midwestern states from Colorado 
to Ohio, and from Kentucky to the Canadian border.  Competitors of the 
Company consist of several very large seed companies and numerous smaller 
operations throughout the Midwestern United States.  The competitors of the 
Company in these markets differentiate their products primarily based on 
price and yield and other agronomic characteristics, as well as on seed 
quality, brand name recognition, and customer service.  The Company believes 
that its products are competitively priced and offer similar agronomic 
characteristics, yield performance, seed quality, and customer service as 
the products of its major competitors in these areas. In the past, the brand 
names under which the Company's products were marketed tended to be regional 
in focus.  However, following the above-described business restructuring and 
redirection, the Company has introduced the "LG" Brand with the intention of 
it becoming a nationally recognized brand.

The alliance with Limagrain allows the Company to position itself to compete 
with other large seed companies on a more effective basis.  Limagrain, 
together with its affiliates ("the Limagrain Group"), being the third 
largest seed company in the world, has extensive research capabilities and 
expertise in the seed industry in which the Company now shares.  In 
particular, the germplasm resources of the Limagrain Group are available to 
the Company.

The benefits of association with the Limagrain Group extend not only to the 
technical side of the business, but also to the extensive management, 
marketing, financial, and personnel resources and expertise of the Limagrain 
Group throughout the world.

Customers

No single domestic customer represents more than 10% of the total revenues 
of the Company for Fiscal 1996, 1995, or 1994.

Export sales to foreign affiliates do represent a significant portion of the 
total net sales of the Company.  Sales to these affiliates consist of 8% of 
net sales for Fiscal 1996, 13% of net sales for Fiscal 1995, and 6% of net 
sales for Fiscal 1994.

Employees

The Company employed 111 people as of August 30, 1996, including 11 part-
time employees.

 
ITEM 2.  PROPERTIES

The following table identifies the properties owned or leased by the Company 
and its subsidiary as of June 30, 1996:
 
                                                            Approximate       
                                           Acreage         Square Footage      

                                            Owned          Owned     Leased

Peoria, IL       Corporate Headquarters                               6,000
Prescott, WI     Office/Warehouse                                    16,056
Mt. Pleasant, IA Office/Plant/Warehouse      20.0         64,000
Tekamah, NE      Office/Plant/Warehouse      17.7         74,620
Decatur, IL      Office/Plant/Warehouse       8.3         59,000
Windfall, IN     Office/Plant/Warehouse       9.9         49,300
Elmwood, IL      Office/Plant/Warehouse      40.5        122,577
Sunfield, MI     Office/Warehouse                                    19,000

Conditioning facilities have peak usage only a few months of the year during 
the fall harvest season of September and October.  Weather conditions at 
harvest time can shorten the time available for harvest, requiring more 
capacity at these locations.  During the fall harvest season, the Company's 
production facilities run at full capacity.  The Company believes it has 
adequate conditioning/warehouse capacity for the effective operation of its 
business.

There is an outstanding mortgage on the Tekamah, Nebraska facility in the 
amount of $138,000.

ITEM 3.  LEGAL PROCEEDINGS

As of August 30, 1996, there are no material pending legal proceedings to 
which the Company or its subsidiary is a party or of which any of 
its property is the subject.


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No matter was submitted to a vote of security holders, through the 
solicitation of proxies or otherwise, during the fourth quarter of the 
fiscal year covered by this report.



PART II

ITEM 5.  MARKET FOR THE REGISTRANT'S COMMON EQUITY AND RELATED SHAREHOLDER 
MATTERS

The common stock of the Company is traded on the NASDAQ Stock Market under 
the symbol BIOT.

No dividends on common equity have been paid since the Company's inception 
and the Company anticipates that for the foreseeable future any earnings 
that would otherwise be available for the payment of dividends to the 
holders of common stock will be retained to partially fund the Company's 
cash requirements.

The Class A Preferred Stock of the Company (all of which is owned by LG 
Corp.) pays a cumulative dividend of $.75 per share per year when declared 
by the Board of Directors.  No such dividend has been declared by the Board 
of Directors.  Pursuant to the terms and conditions of the Company's Class A 
Preferred Stock, should any dividend be declared or paid on the common stock 
of the Company, the holders of Class A Preferred Stock would be entitled to 
receive dividends at a rate per share equal to that of the common stock.

Pursuant to the line of credit arrangement with its bank, the Company has 
agreed that the payment of dividends in any fiscal year, if any, will not 
exceed the Company's net income determined on a consolidated basis.  If the 
Company is in default on any of the terms of the Credit Agreement, then the 
Company may not pay or declare any dividends, other than dividends payable 
in stock of the Company.

As of August 30, 1996 there were approximately 597 shareholders of record of 
the Company's common stock, representing approximately 1,964 beneficial 
owners.  As of August 30, 1996, the closing price per share of common stock 
was $0.4375.
<TABLE>
Price range of common stock:

                                          High Last Sale    Low Last Sale
<CAPTION>
<S>                                           <C>              <C>
Quarter Ended 
  June 30, 1996                               $  7/8           $ 1/2
  March 31, 1996                               1 1/8             3/8
  December 31, 1995                            15/16             5/16
  September 30, 1995                           1 7/8             9/32

Quarter Ended
  June 30, 1995                                11/32             3/16
  March 31, 1995                                5/16             3/16
  December 31, 1994                            13/32             3/16
  September 30, 1994                           21/32             5/16

</TABLE>

ITEM 6.  SELECTED CONSOLIDATED FINANCIAL AND OPERATING DATA

The following table sets forth selected consolidated financial and operating 
data for the Company and its predecessors for the periods and at the dates 
indicated.  The selected consolidated operating and financial data presented 
below was derived from the Consolidated Financial Statements of the Company, 
which were audited by KPMG Peat Marwick LLP, independent auditors.  The 
table should be read in conjunction with the Consolidated Financial 
Statements, related notes, and other financial information.

The fiscal years ended June 30, 1994 through 1996 reflect the reverse 
acquisition accounting of the Limagrain Transaction and are not comparable 
with years prior to 1994 that represent Shissler only.  As discussed in 
"ITEM 1.  BASIS of PRESENTATION," Fiscal 1994 contains twelve months of 
Shissler standing alone plus five months of the Company as it was 
constituted prior to the Limagrain Transaction.
<TABLE>
                                        For Years Ended June 30,        
                    1996*        1995*        1994*        1993**     1992**    
                                 ($000's, except per share data)  
<CAPTION>
<S>                <C>         <C>          <C>         <C>         <C>
Operations:
 Net Sales 
 Domestic          $17,151     $ 20,434     $ 23,005    $  4,768    $ 4,985
 Export-Affiliate    1,489        3,089        1,582       3,187      2,193
 -Export-Other         127          438           --         284         --
Operating income    (2,594)      (1,531)        (477)        411        232
Net interest expense  (832)      (1,068)        (405)        (55)       (96)
Other income (expense) 726          272           50          10         45
Income taxes           (15)          67           --         148         76
Net income (loss)
before extraordinary 
item               $(2,685)     $(2,394)     $  (832)     $  218     $  105    
Extraordinary item-	
  utilization of NOL    --           --           --          84         76
Net income (loss)  $(2,685)     $(2,394)     $  (832)     $  302     $  181
Net income (loss)
per common share:  $ (0.03)     $ (0.02)     $ (0.01)     $ 0.00     $ 0.00

Cash Dividends Declared
per common share   $    --      $    --      $    --      $   --     $   --
 
Balance Sheet:
Cash and cash
 equivalents       $   194      $   399      $ 1,141      $   418    $   185
Property, plant and
 equipment, net      9,722        9,771       10,950        5,723      5,908
Total assets        32,957       34,502       39,320        9,925     10,000
Notes payable and 
 long-term debt        201          285          513          --          20
Due to affiliate
 long-term           3,261        5,326        3,260        2,261      2,261
Shareholder equity $16,105      $16,790      $17,245      $ 6,657    $ 6,355

*Post-acquisition
**Pre-acquisition
</TABLE>

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
RESULTS OF OPERATIONS

LIQUIDITY AND CAPITAL RESOURCES

Since October 1993, the Company has had a revolving credit arrangement, 
renewable annually, (the "Line of Credit"), whereby the Company may borrow 
up to $12,000,000 subject to the limitations of a borrowing base formula and 
other limitations contained in the Limagrain Agreement.  Borrowings under 
the Line of Credit are secured by the inventory and accounts receivable of 
the Company and its subsidiaries, and by the guarantees of Limagrain, LG 
Corp. and LG Seeds, Inc. Borrowings outstanding under the Line of Credit at 
June 30, 1996 and 1995 totaled $8,500,000 and $9,200,000, respectively.  The 
Company has been in compliance with all loan covenants since August 1994.

Effective November 30, 1995, the Line of Credit was extended until December 
1, 1996.  Management expects that this Line of Credit will be renewed under 
substantially the same conditions for one year at that time and that the 
Company will have access to sufficient cash resources to meet the reasonably 
foreseeable obligations of its continuing business operations.  Management 
believes there is a strong commitment by Limagrain to enable the Company to 
obtain sufficient working capital to support the business.  Management's 
belief that Limagrain's support will continue is based on Limagrain's 
commitment under the Line of Credit guarantee (which it has not had the 
legal obligation to continue since November 1994), the additional 
contribution of $9,000,000 for Preferred Stock, and the advance of 
$3,261,000 in long-term borrowing.  Limagrain has no legal obligation to 
provide additional funding for the Company.

On June 29, 1994, the Company executed a Debt Restructuring Agreement by and 
among the Company, Shissler, LG Corp. and Limagrain.  This Debt 
Restructuring Agreement converted all of the outstanding cash advances and 
promissory notes due to Limagrain and LG Corp. by the Company and Shissler 
to long-term debt and equity in the Company.  The total amount of 
outstanding debt to affiliates on that date, $8,261,000, was converted to 
(i) a two-year unsecured promissory note in the amount of $3,261,000 and 
(ii) 500,000 shares of the Company's Class A Preferred Stock, in exchange 
for the remaining $5,000,000 of outstanding indebtedness.  The two-year 
promissory note is subordinate to the Line of Credit and bears interest at 
0.4375% above the one-year LIBOR rate as of July 1 for the following twelve 
month period, payable annually.  (See Notes 7 and 8 of the "NOTES TO 
CONSOLIDATED FINANCIAL STATEMENTS.")  

As of June 30, 1996, the promissory note in the amount of $3,261,000 was 
extended until July 1, 1998.  All other terms and conditions remain the same 
as the prior note.

On November 30, 1994, LG Corp. converted a $4,000,000 Cash Advance into (i) 
a two-year, long-term note for $2,000,000 bearing interest at LIBOR plus 
1.15%, and (ii) 200,000 shares of Class A Preferred Stock of the Company.  
(See Notes 7 and 8 of the "NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS.")  

On November 30, 1995, the Company converted the $2,000,000 long-term note 
owed to LG Corp. into an additional 200,000 shares of Class A Preferred 
Stock.

On July 31, 1996, the Company received a long-term cash advance from an 
affiliate in order to help fund operations of the Company.  On August 30, 
1996, this long-term cash advance was re-negotiated and increased to a 
$2,000,000 note with LG Corp. bearing interest at 7% and due July 1, 1998.

There is no assurance that LG Corp., or any other affiliate of Limagrain, 
will continue to (i) guarantee the Line of Credit, (ii) loan funds to the 
Company, or (iii) convert such loans to preferred stock.  In addition, there 
is no assurance that, without such guarantees, loans,  and/or conversions, 
the Company would not be out of compliance with (a) the Line of Credit, or 
(b) the NASDAQ Stock Market quantitative maintenance criteria, during 
seasonal fluctuations in the Company's borrowing base and net tangible 
assets, respectively.

Fiscal 1996

During Fiscal 1996, Cash and cash equivalents decreased by $205,000. The 
Company has a policy of using excess cash to reduce the principal amount 
outstanding under its Line of Credit.  As of June 30, 1996, the Company had 
a cash balance of $194,000.

Cash flow used in operations totaled $1,074,000 in Fiscal 1996. This 
consisted of a net loss of $2,685,000, a non-operating gain on disposal of 
assets of $405,000, an increase in receivables of $186,000 and a decrease in 
accounts payable and accrued liabilities of $178,000 which were partially 
offset by $1,402,000 in depreciation and amortization, a $951,000 decrease 
in inventory and a $27,000 reduction in other current assets.

Cash flow from investing activities used $449,000 of the Company's cash.  
Capital expenditures totaled $1,527,000 with $1,383,000 of that amount 
relating to the replacement of the Elmwood building destroyed by fire in 
August of 1995. These expenditures were partially funded by  $1,078,000 in 
proceeds from asset sales of which $1,029,000 is insurance proceeds from the 
replacement cost insurance policy covering the building destroyed by fire.  
The net book value of this building was $646,000.  The resulting gain of 
$383,000 is classified as part of gain on disposition of fixed assets.  The 
Company has entered into a contract to replace this destroyed building with 
a new, modern grading and treating building with a total projected cost of 
$1,881,000.  As of June 30, 1996, $1,383,000 had been spent and is included 
in the construction in progress account.

Cash flow provided by financing activities totaled $1,318,000. The issuance 
of $2,000,000 in Class A Preferred Stock to LG Corp. and $2,175,000 increase 
in short term debt to affiliates more than offset the $2,000,000 decrease in 
long-term debt to LG Corp. (which resulted from the issuance of the Class A 
Preferred Stock), the $700,000 decrease in the line of credit and the 
$92,000 decrease in long-term debt and notes payable.

Fiscal 1995

During Fiscal 1995, Cash and Cash equivalents decreased by $742,000. As of 
June 30, 1995, the Company had a cash balance of $399,000.

Cash flow used in operations totaled $176,000 in Fiscal 1995.  This amount 
consisted of net loss of $2,394,000 and a decrease in accounts payable and 
accrued liabilities of $1,299,000 which were partially offset by $1,553,000 
in depreciation and amortization, a $852,000 decrease in receivables, a 
$415,000 decrease in inventory and a $697,000 decrease in other current 
assets.

Cash flow from investing activities provided the Company with $559,000 in 
cash.  Capital expenditures used $237,000 in cash but were offset by 
$647,000 in cash received from the sale of non-operating assets.  A 
reduction in long-term assets provided $149,000 in cash.

Cash flow used for financing activities amounted to $1,125,000.  Borrowings 
under the line of credit were decreased $4,600,000, long-term debt and notes 
payable were reduced $377,000, and Class A common stock declined $61,000 
from the repurchase of 6,054,751 shares from State Farm.  These reductions 
in debt and equity were partially funded by a $2,000,000 increase in equity 
from the issuance of Preferred Stock to LG Corp. and a net $1,913,000 
increase in debt with LG Corp.

Fiscal 1994  (See "ITEM 1.  BUSINESS -- BASIS OF PRESENTATION")

During Fiscal 1994, Cash and Cash Equivalents increased by $723,000.  As of 
June 30, 1994, the Company had a cash balance of $1,141,000.

Net cash used in operations totaled $4,665,000 during Fiscal 1994.  This 
amount consisted of net loss of $832,000, offset by depreciation and 
amortization of $1,140,000 and a decrease in inventories of $7,477,000.  
Additional items that consumed cash were an increase in accounts receivable 
of $4,566,000, a decrease in accounts payable and accrued liabilities of 
$7,642,000, and an increase in other current assets of $242,000.

Cash flow provided by investing activities was $445,000.  This consisted of 
$62,000 in capital expenditures offset by $352,000 in cash acquired as a 
result of the reverse acquisition accounting treatment of the Limagrain 
Transaction and the collection of long-term, non-trade receivables totaling 
$155,000.

Cash was generated by financing activities in the amount of $4,943,000.  The 
principal amount outstanding under the Line of Credit was reduced by 
$900,000; however, debts to affiliates increased by $947,000.  The majority 
of the cash generated from financing activities came from the $5,000,000 in 
Class A Preferred Stock issued to LG Corp.


RESULTS OF OPERATIONS

As discussed in "ITEM 1.  BUSINESS -- BASIS OF PRESENTATION," the actual 
audited financial statements for Fiscal 1996, 1995, and 1994 do not lend 
themselves to meaningful comparisons as the relevant entity for each period 
is significantly different.

Consequently, management has prepared the following unaudited proforma 
financial statements in an attempt to depict more accurately changes in the 
operations of the combined entity as it exists today.

The following is a discussion of significant trends represented in these 
proforma financial statements.

Proforma Financial Statements

The following proforma consolidated statements of operations for the years 
ended June 30, 1996, 1995, and 1994 reflect the combined results of the 
Company and Shissler as if the Limagrain Transaction had been consummated at 
the beginning of the years presented, and as if Scott Seed and Donley had 
been sold at the beginning of the years presented.  These statements present 
the comparative operations of the Company as it existed on June 30, 1996.

Adjustments are included to record depreciation and amortization of the 
Company's assets based upon the purchase accounting as described in "ITEM 1.  
BUSINESS--THE LIMAGRAIN TRANSACTION."  Pursuant to a Termination of 
Employment Agreement between the Company and the former President and Chief 
Executive Officer of the Company, effective as of the Second Closing, the 
Company paid to the former officer a one-time gross lump-sum severance 
payment of $200,000.  This severance payment is not reflected in the 
accompanying proforma statements.

These proforma statements were prepared based on the results of the Company 
as it exists today, without Scott Seed and Donley.  As discussed earlier, 
the Company now conducts business from seven service centers strategically 
located throughout the corn growing area of the Midwest.  The Company 
produces and processes corn, soybean and wheat seeds at only four locations 
(which are also service centers) in order to improve product quality and 
increase efficiency.  Quality testing is done at the Company's Elmwood, 
Illinois facility in order to assure uniform quality of products.
<TABLE>
                        Results of Operations (Proforma)

                        BIOTECHNICA INTERNATIONAL, INC.
                  PROFORMA CONSOLIDATED STATEMENTS OF OPERATIONS
                   (Unaudited - Excludes Donley and Scott Seed)
                           (in thousands of dollars)

                          	         12 months Ended June 30,
                             	   1996             1995           1994
<CAPTION>
  <S>                        <C>              <C>             <C>
NET SALES:
  Domestic                   $ 17,151         $ 16,988        $20,284 
  Export                        1,616            3,527          1,582
                               ------          -------        -------
                               18,767           20,515         21,866
COST AND OPERATING EXPENSES:
  Cost of goods sold           12,990           12,628         16,901
  Sales and marketing           4,203            4,122          5,429
  Warehouse and distribution    1,196            1,630          1,397           
  General and administrative    2,473            3,061          4,392
  Amortization of goodwill        499              479            282         
                               ------           ------         ------
                               21,361           21,920         28,401

     Operating Loss            (2,594)          (1,405)        (6,535)

OTHER INCOME (EXPENSE):
  Interest expense               (832)          (1,065)          (915)
  Gain on disposal-fixed assets   405                0              0  
  Other                           321              211             46   
                              -------          -------        -------
     Net loss before taxes    $(2,700)         $(2,259)       $(7,404)
                              =======          =======        =======  
</TABLE>

FISCAL 1996 COMPARED TO PROFORMA FISCAL 1995

Domestic Sales

The Company had domestic seed sales in Fiscal 1996 of $17,151,000, compared 
to $16,988,000 in Fiscal 1995.  Due primarily to the changes in the Federal 
government's farm programs, acreage devoted to corn and soybeans increased 
by approximately 8% in the Company's marketing area.  Corn sales increased 
by almost that rate, indicating that the Company was able to maintain its 
market share in spite of major availability problems for many of its 
premier, newly-introduced hybrids.  This increase was offset by a decrease 
in alfalfa sales.  Late snow cover across the Dairy Belt region of 
Minnesota, Wisconsin, and Michigan, where the Company sells most of its 
alfalfa, resulted in low planting of spring alfalfa.  In addition, the 
growing conditions during the summer of 1995 resulted in smaller soybean 
seeds being produced.  Since soybean seeds are sold in 50 pound bags, there 
were more seeds per bag.  This resulted in fewer bags required to plant the 
same number of acres compared to the prior year.  Domestic net sales changes 
were:
                        Proforma Fiscal 1995                   $16,988
                        Increase in Domestic Corn                  939
                        Decrease in Alfalfa                       (380)
                        Decrease in Soybeans                      (440)
                        Other                                       44
                                                               ------- 
                          Proforma Fiscal 1996                 $17,151
                                                               =======
Export Sales

Export sales for Fiscal 1996 showed a decrease compared to Fiscal 1995.  
Fiscal 1996 sales were $1,616,000, compared to Fiscal 1995 sales of 
$3,527,000.  Of these amounts, sales to affiliates amounted to $1,489,000 
and $3,089,000, respectively.  Since most export sales are based on annually 
negotiated production contracts - negotiated at arms-length by management of 
the Company and a representative of the respective affiliate - the decrease 
in sales was the result of disappointing production yields during the Fall 
of 1994 and lower demand by affiliated companies in Europe.  Typically, high 
export sales to Europe in one year translate into lower sales in the 
following year, as the affiliates have a larger carryover inventory to sell.  
(See "ITEM 1.  BUSINESS--CONTINUING BUSINESS.")  There is no assurance that 
the Company and the Limagrain affiliates will continue to reach agreement on 
such export sales arrangements in the future and, in such event, there would 
be a negative impact upon the Company's sales and profit margins.

Cost of Goods Sold

Cost of goods sold was significantly higher in Fiscal 1996 than in Fiscal 
1995.  This resulted primarily from high production costs caused by the poor 
growing conditions during the Summer of 1995.  This resulted in lower yields 
and higher costs per unit.  These higher costs per unit accounted for 
approximately $1,200,000 in higher costs.

Warehouse and Distribution

Warehouse and distribution costs were $1,196,000 in Fiscal 1996, compared to 
$1,630,000 in Fiscal 1995.  This reduction resulted from organizational 
efficiencies at the Company's warehouses and improved management of freight 
and other distribution costs.

Sales and Marketing

Sales and marketing costs were $4,203,000 in Fiscal 1996, compared to 
$4,122,000 in Fiscal 1995.  Sales and marketing costs were relatively stable 
due to a relatively constant sales volume.

General and Administrative

A significant goal of the Company for Fiscal 1996 was the reduction of 
general and administrative expenses.  These costs were reduced by $588,000. 
Included in that amount was a reduction of general and administrative costs 
of $150,000 resulting from the expiration or repurchase of incentive stock 
options.  Additionally, Fiscal 1995 costs included administrative costs 
associated with the reorganization, redirection, and divestment efforts of 
the Company.

Interest Expense

Interest expense was lower in Fiscal 1996 than in Fiscal 1995 by $233,000.  
This was generated primarily by reduced interest rates and lower borrowings 
from affiliates subsequent to the conversion of $2,000,000 in long-term debt 
into Preferred Stock as described above. 

Gain on Disposition of Fixed Assets

The increase in gain on disposition of fixed assets resulted primarily from 
the recognition of the $383,000 gain on the involuntary conversion of the 
Grading Building at Elmwood due to fire in August, 1995.

Net Loss Before Taxes

Proforma net loss before taxes shows a deterioration for Fiscal 1996 
compared to Fiscal 1995 of $441,000.  


PROFORMA FISCAL 1995 COMPARED TO PROFORMA FISCAL 1994

Domestic Sales

The Company had domestic seed sales in Fiscal 1995 of $16,988,000, compared 
to $20,284,000 in Fiscal 1994. Corn acres decreased 11% due to (i) an 
increase in government set aside programs and (ii) an unusually wet spring 
throughout much of the Company's marketing area.  The wet spring resulted in 
some farmers switching from corn to soybean planting or letting fields go 
unplanted.  Sales volume was also affected by a more selective approach of 
not selling to farmer-customers who had a history of poor payment practices.  
There was also some loss of business resulting from the major reorganization 
of the Company and the major realignment of the sales force.  

Export Sales

Export sales for Fiscal 1995 showed a significant increase over Fiscal 1994.  
Fiscal 1995 sales were $3,527,000, compared to Fiscal 1994 sales of 
$1,582,000. Of these amounts, sales to affiliates amounted to $3,089,000 and 
$1,582,000, respectively. Export sales tend to fluctuate from year to year 
as discussed above.  There is no assurance that the Company and the 
Limagrain affiliates will continue to reach agreement on such export sales 
arrangements in the future and, in such event, there would be a negative 
impact upon the Company's sales and profit margins.

Cost of Goods Sold

Cost of goods sold was significantly lower in Fiscal 1995 than in Fiscal 
1994.  This resulted primarily from two factors.  

First, during Fiscal 1994, cost of goods sold had been increased due to the 
write-off of $3,297,000 in obsolete inventory.  During Fiscal 1995, the 
Company wrote off an additional $568,000 in obsolete inventory.  The high 
write-offs in Fiscal 1994, and the still higher than normal write-offs in 
Fiscal 1995, resulted from careful review of the product line of the Company 
and a stringent approach to product quality.  As of June 30, 1995, the 
Company consolidated the product lines of the various service centers. 
Management's goal is to evaluate genetics available from many sources 
(including Limagrain) and to market what is considered to be the best 
varieties available in the different geographic regions of the marketing 
area.

Second, the Company benefited from reduced costs as a result of the very 
good growing conditions and yields during the Fall of 1994.  These 
conditions allowed the Company to spread fixed costs over a higher number of 
units.  In addition, the Company initiated a program of cost control in all 
areas and gained efficiencies from closing two production locations and 
consolidating production.

Sales and Marketing

Sales and marketing costs were $4,122,000 in Fiscal 1995, compared to 
$5,429,000 in Fiscal 1994.  Although a portion of this reduction resulted 
from lower sales volume, most of the savings resulted from a major 
realignment of our sales and marketing effort.  In the past, each of the 
different BioTechnica "companies" operated independently.  As such, the 
Company may have had two district sales managers representing two different 
companies covering the same territory, often calling on the same prospects.  
After the realignment, each marketing area (normally a state or states) is 
serviced by one service center. The Company now has a group of sales 
managers assigned a particular service center, each of whom are assigned a 
group of counties in a particular state (district or area). The Company has 
assigned all former dealers of any previous BioTechnica "company" within 
that district to that sales manager.  The dealers continue to receive the 
same brands of product as before, but they are serviced by only one sales 
manager, they place orders at a local service center, and product is shipped 
from that service center. Because of this realignment, the Company has 
eliminated approximately twenty-five district sales manager positions while 
maintaining the same dealer force.  Management believes this realignment 
will enhance the relationship between the Company, its dealers, and its 
customers.

General, Administrative, and Other

A significant goal of the Company for Fiscal 1995 was the reduction of 
general and administrative expenses.  These costs were reduced by 
$1,331,000.  As part of the overall reorganization of the Company, much 
effort has been put into reorganizing and centralizing the administrative 
functions of the Company.  Whereas all of the former "companies" had full, 
in-house administrative and accounting staffs, including a controller, now 
each service center has an office manager and one or two 
sales/administrative assistants who handle the clerical functions required 
to service our customers.  Most accounting and other administrative tasks 
are performed at the corporate office in Peoria, Illinois.

Interest Expense

Interest expense was higher in Fiscal 1995 than in Fiscal 1994 by $150,000.  
The addition of $5,000,000 in equity by LG Corp. as of June 30, 1994 and 
$2,000,000 in equity by LG Corp. as of November 30, 1994 reduced the need to 
borrow and pay interest.  The resulting reduction was offset by higher 
market interest rates in Fiscal 1995.

Net Loss Before Taxes

Proforma net loss before taxes shows an improvement for Fiscal 1995 compared 
to Fiscal 1994 of $5,145,000.  This improvement is the direct consequence of 
the in-depth restructuring initiated at the end of Fiscal 1994 allowing the 
Company to (i) reduce costs very significantly; and (ii) improve production 
efficiencies (see "ITEM 1.  BUSINESS--BUSINESS RESTRUCTURING AND 
REDIRECTION").  However, the lower sales volume and the costs associated 
with the final phase of the restructuring process partially offset the 
favorable factors discussed above (see "Sales and Marketing" above).

 ACCOUNTING STANDARDS

Statement of Financial Accounting Standard No. 121, "Accounting for the 
Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of" 
was issued in March 1995 and is effective for fiscal years beginning after 
December 15, 1995.  Management continues to assess the effects of the 
provisions of the Statement on the financial condition and results of 
operations of the Company, and has determined that no adjustment to asset 
carrying values is required at this time.


ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SCHEDULE

										Page
   Consolidated Financial Statements:				       Number

     Independent Auditors' Report                                    14 
                                   
     Consolidated Balance Sheets at June 30, 1996 and 1995           15

     Consolidated Statements of Operations for the years             16
     ended June 30, 1996, 1995 and 1994  
                             
     Consolidated Statements of Cash Flows for the years             17
     ended June 30, 1996, 1995 and 1994                                     
     
     Consolidated Statements of Changes in Shareholders'           18-20 
     Equity for the years ended June 30, 1996, 1995 
     and 1994    

     Notes to Consolidated Financial Statements                    21-27  



   Consolidated Financial Statement Schedule:

     Valuation and Qualifying Accounts - Schedule II                 28


All other schedules have been omitted because the required information is 
not applicable or not present in amounts sufficient to require submission of 
the schedule, or because the information required is included in the 
consolidated financial statements or the notes thereto.

INDEPENDENT AUDITORS' REPORT

The Board of Directors and Shareholders
BioTechnica International, Inc.:



We have audited the consolidated financial statements of BioTechnica 
International, Inc. and subsidiary (the Company) as listed in the 
accompanying index.  In connection with our audits of the consolidated 
financial statements, we also have audited the financial statement schedule 
as listed in the accompanying index.  These consolidated financial 
statements and financial statement schedule are the responsibility of the 
Company's management.  Our responsibility is to express an opinion on these 
consolidated financial statements and financial statement schedule based on 
our audits.

We conducted our audits in accordance with generally accepted auditing 
standards.  Those standards require that we plan and perform the audit to 
obtain reasonable assurance about whether the financial statements are free 
of material misstatement.  An audit includes examining, on a test basis, 
evidence supporting the amounts and disclosures in the financial statements.  
An audit also includes assessing the accounting principles used and 
significant estimates made by management, as well as evaluating the overall 
financial statement presentation.  We believe that our audits provide a 
reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above 
present fairly, in all material respects, the financial position of 
BioTechnica International, Inc. and subsidiary as of June 30, 1996 and 1995, 
and the results of their operations and their cash flows for each of the 
years in the three-year period ended June 30, 1996, in conformity with 
generally accepted accounting principles.  Also in our opinion, the related 
financial statement schedule, when considered in relation to the basic 
consolidated financial statements taken as a whole, presents fairly, in all 
material respects, the information set forth therein.


                                        			KPMG PEAT MARWICK LLP



Chicago, Illinois
July 25, 199
<TABLE>

                     BIOTECHNICA INTERNATIONAL, INC.
                      CONSOLIDATED BALANCE SHEETS
                       (in thousands of dollars)

                                                June 30,          June 30,
                                                  1996              1995        
<CAPTION>
   ASSETS 
<S>                                             <C>               <C>
Current assets:
  Cash and cash equivalents                     $   194            $  399
  Accounts receivable, less allowance for doubtful
   accounts of $90 in 1996 and $123 in 1995       7,964             7,778
  Inventories                                     5,976             6,927       
  Prepaid expenses and other current assets         153               105    
                                                 ------            ------ 
       Total current assets                      14,287            15,209
               
Net property, plant and equipment                 9,722             9,771

Goodwill and other assets, net                    8,948             9,522       
                                                -------           -------
     Total assets                               $32,957           $34,502
                                                =======           =======

    LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
  Borrowings under line of credit               $ 8,500           $ 9,200
  Current portion of long-term debt                 107               115
  Accounts payable                                1,013               735    
  Accrued liabilities                             1,595             2,051    
  Due to affiliates                               2,175                -- 
                                                 ------            ------
     Total current liabilities                   13,390            12,101    

Long-term debt                                       31               129
Due to affiliates                                 3,261             5,326    
Other noncurrent liabilities                        170               156
                                                -------           -------
     Total liabilities                          $16,852           $17,712

Shareholder equity:                    
  Preferred stock, Class A, 900,000 and 700,000  
     shares outstanding at June 30, 1996 and 1995,
     respectively                              $      9           $     7
  Common stock, 115,418,788 shares outstanding
     at June 30, 1996 and 1995                    1,154             1,154
  Additional paid-in capital                     20,891            18,893
  Accumulated deficit                            (5,854)           (3,169)    
  Treasury stock                                    (95)              (95)
                                                 ------            ------
     Total shareholders' equity                 $16,105           $16,790       

Commitments (note 12)
     Total liabilities and shareholder equity   $32,957           $34,502 
                                                =======           =======

           See accompanying notes to consolidated financial statement
</TABLE>
<TABLE>
                     BIOTECHNICA INTERNATIONAL, INC.
                 CONSOLIDATED STATEMENTS OF OPERATIONS
          (in thousands of dollars, except per share amounts)

                                          Years Ended June 30,
                                   1996              1995              1994
<CAPTION>
<S>                          <C>               <C>               <C>
Net Sales:
  Domestic                     $ 17,151          $ 20,434          $ 23,005     
  Export-Affiliates               1,489             3,089             1,582
  Export-Other                      127               438                --     
                                 ------            ------            ------
                                 18,767            23,961            24,587
Costs and Operating Expenses:
  Cost of goods sold             12,990            15,432            17,831
  Sales and marketing             4,203             4,293             3,418
  Warehouse and distribution      1,196             2,043             1,255     
  General and administrative      2,473             3,245             2,371
  Amortization of goodwill          499               479               189
                                 ------            ------            ------
     Operating loss              (2,594)           (1,531)             (477)


Other income (expense):
  Interest expense                 (832)           (1,068)             (405)
  Gain on disposal-fixed assets     405                 0                --
  Other                             321               272                50
                                 ------            ------            ------ 

  Net loss before income taxes   (2,700)           (2,327)             (832)

  Income tax expense (benefit)      (15)               67                -- 
                                -------           -------           -------
 
     Net Loss                   $(2,685)          $(2,394)          $  (832) 
                                =======           =======           =======

Net Loss per common share       $ (0.03)          $ (0.02)          $ (0.01) 
                                =======           =======           =======   
Weighted Average 
Shares Outstanding           115,419,000       121,385,000       107,435,000  
                             ===========       ===========       ===========

         See accompanying notes to consolidated financial statement
</TABLE>
<TABLE>
                       BIOTECHNICA INTERNATIONAL, INC.
                   CONSOLIDATED STATEMENTS OF CASH FLOWS
                        (in thousands of dollars)

                                               Years Ended June 30,            
                                         1996           1995          1994
<CAPTION>
<S>                                  <C>            <C>            <C>
Cash Flow from Operating Activities:
  Net loss                           $ (2,685)      $ (2,394)      $  (832)     
  
  Adjustments to reconcile net loss
     to net cash used in operating activities:
     Depreciation                         903          1,074           951
     Amortization                         499            479           189
     Gain on disposal-fixed assets       (405)            --            -- 
     
  Changes in assets and liabilities:
      Accounts receivable                (186)           852        (4,566)
      Inventories                         951            415         7,477
      Other assets                         27            697          (242)     
      Accounts payable and accrued
       liabilities                       (178)        (1,299)       (7,642)
                                       -------        -------       -------     
                                    
Net cash used in operating activities  (1,074)          (176)       (4,665) 
                                       -------        -------       -------

Cash Flow from Investing Activities:
  Acquisition of property, plant
     and equipment                     (1,527)          (237)          (62)  
  Proceeds from asset sales             1,078            647            --    
  Cash of business acquired                --             --           352     
  Other                                    --            149           155     
                                       -------        -------       -------
     Net cash provided by (used in)
       investing activities              (449)           559           445      
                                       -------        -------       -------
Cash Flow from Financing Activities:
  Net repayment under line of credit     (700)        (4,600)         (900)  
  Increase (Decrease)in long-term debt  
    to affiliates                      (2,065)         2,066         1,000  
  Increase (Decrease) in short-term debt  
    to affiliates                       2,175           (153)          (53)   
  Decrease in long-term debt and
     notes payable                        (92)          (377)         (104)    
  Repurchase of Class A common stock       --            (61)           -- 
  Issuance of Class A Preferred Stock   2,000          2,000         5,000   
                                       -------        -------       -------
       Net cash provided by (used in)
         financing activities           1,318         (1,125)        4,943 
                                       -------        -------       -------
       Net increase (decrease) in
         cash and cash equivalents       (205)          (742)          723    
                                       -------        -------       -------
Cash and cash equivalents at
   beginning of year                   $  399        $ 1,141       $   418 
                                       -------       --------      --------
Cash and cash equivalents at
   end of year                         $  194        $   399       $ 1,141
                                       =======       ========      ======== 

          See accompanying notes to consolidated financial statement

</TABLE>
<TABLE>
                     BIOTECHNICA INTERNATIONAL, INC.
       CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
              (in thousands of dollars, except share data)

                    Preferred Stock                        Common Stock
                  Class A Non-Voting    Common Stock    Class A Non-Voting
                   Shares  Par Value   Shares  Par Value   Shares  Par Value
<CAPTION>
<S>                <C>        <C>   <C>           <C>      <C>         <C>
Balance June 30, 1993 
 (pre-acquisition)    --      $ --        5,000      $ 5      --       $ --
 
Limagrain Transaction          
  Acquisition of existing
   common stock       --        --    8,135,741       81   10,753,087   108
  Issuance of common
   stock              --        --   97,777,178      978      --         --
  Receipt of Shissler
   common stock       --        --       (5,000)      (5)     --         --

Issuance of Preferred
  Stock            500,000       5          --        --      --         --

Net loss for 
  Fiscal 1994         --        --          --        --      --         --
                   -------     ---- -----------   -------  ----------  ----
Balance June 30, 1994 
(post-acquisition) 500,000     $ 5  105,912,919   $1,059   10,753,087  $108

Issuance of Preferred
  Stock            200,000       2          --        --      --         -- 

Conversion of Class A
  & B Shares          --        --    9,505,869       95   (4,698,336)  (47)

Repurchase of Class A
 Shares               --        --         --         --   (6,054,751)  (61)

Net loss for
  Fiscal 1995         --        --         --         --      --         --
                   -------     ---  -----------   ------    ---------- ----  
Balance June 30, 1995
(post-acquisition) 700,000     $ 7  115,418,788   $1,154      --       $ --

Issuance of Preferred
  Stock            200,000       2         --         --      --         -- 

Net loss for
  Fiscal 1996         --        --         --         --      --         --
                   -------     ---  -----------   ------    ---------- ----
Balance June 30, 1996
(post-acquisition) 900,000     $ 9  115,418,788   $1,154      --       $ --
                   =======     ===  ===========   ======     ========= ====
                                                                      
(Continued)

       See accompanying notes to consolidated financial statement
</TABLE>
<TABLE>

                     BIOTECHNICA INTERNATIONAL, INC.
      CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
              (in thousands of dollars, except share data)

                  Common Stock
               Class B Non-Voting     Additional       Retained Earnings 
               Shares   Par Value   Paid-In Capital  (Accumulated Deficit)
<CAPTION>
<S>            <C>           <C>           <C>                <C>
Balance June 30, 1993
(pre-acquisition)  --        $  --         $ 6,595              $  57

Limagrain Transaction          

Acquisition of existing
common stock    4,807,533       48           5,305                 --
Issuance of common
stock              --           --              --                 --
Receipt of Shissler
common stock       --           --              --                 --

Issuance of Preferred
  Stock            --           --           4,995                 --

Net loss for 
  Fiscal 1994      --           --              --               (832) 
                ---------     ----          ------             ------    
Balance June 30, 1994 
(post-acquisition)
                4,807,533      $48         $16,895              $(775)

Issuance of Preferred
  Stock            --           --           1,998                 -- 

Conversion of Class A
  & B Shares   (4,807,533)     (48)             --                 --

Repurchase of Class A
  Shares           --           --              --                 --

Net loss for 
  Fiscal 1995      --           --              --             (2,394)
                ---------    -----         -------            --------
Balance June 30, 1995
(post-acquisition) --        $  --         $18,893            $(3,169)

Issuance of Preferred
  Stock            --           --           1,998                 -- 

Net loss for 
  Fiscal 1996      --           --              --             (2,685)
                ---------    -----         -------            --------
Balance June 30, 1996
(post-acquisition) --        $  --         $20,891            $(5,854)
                =========    =====         =======            ========
(Continued)
           See accompanying notes to consolidated financial statement
</TABLE>
<TABLE>
                   BIOTECHNICA INTERNATIONAL, INC.
     CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
            (in thousands of dollars, except share data)

                                                                   Total
                                 Treasury Stock                Shareholders'
                                Shares   Par Value                Equity 
<CAPTION>
<S>                            <C>          <C>                  <C>
Balance June 30, 1993
 (pre-acquisition)                --        $ --                  $ 6,657

Limagrain Transaction           
  Acquisition of existing
   Common stock                (39,160)      (95)                   5,447
  Issuance of common
   Stock                          --          --                      978
  Receipt of Shissler
   Common stock                   --          --                       (5)

Issuance of Preferred
  Stock                           --          --                    5,000

Net loss for 
  Fiscal 1994                     --          --                     (832)
                               --------     -----                 --------     
Balance June 30, 1994 
 (post-acquisition)            (39,160)     $(95)                 $17,245

Issuance of Preferred
  Stock                           --          --                    2,000

Conversion of Class A
  & B Shares                      --          --                      --

Repurchase of Class A
  Shares                          --          --                      (61)
 
Net loss for 
  Fiscal 1995                     --          --                   (2,394)
                               --------     -----                ---------
Balance June 30, 1995                 
 (post-acquisition)            (39,160)     $(95)                $ 16,790

Issuance of Preferred
  Stock                           --          --                    2,000

Net loss for 
  Fiscal 1996                     --          --                   (2,685)
                               --------     -----                ---------
Balance June 30, 1996
 (post-acquisition)            (39,160)     $(95)                $ 16,105
                               ========     =====                ========= 

          See accompanying notes to consolidated financial statements
</TABLE>

BIOTECHNICA INTERNATIONAL, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A.  Business
BioTechnica International, Inc. and its subsidiary, LG Seeds, Inc. (the 
"Company"), sells corn, soybean, alfalfa and other seed to dealers, 
distributors and farmers through its seed operations.  The Company operates 
in a twelve-state region centered in the Midwestern United States.  Sales 
are generally made on open account to customers.  Because of the geographic 
concentration of the Company's customers in the Midwest, it is significantly 
dependent upon the weather and market conditions in its market areas.  In 
addition, industry sales levels are dependent upon factors resulting from 
governmental agriculture policies and farm programs.

As a result of a series of transactions culminating on March 7, 1994 (the 
"Limagrain Transaction"), at the 1993 Annual Meeting of Shareholders of the 
Company, voting and management control of the Company was obtained by 
Limagrain Genetics Corporation ("LG Corp.").  LG Corp. is a subsidiary of 
Groupe Limagrain Holding ("Limagrain") of Chappes, France.  As part of the 
Limagrain Transaction, Shissler Seed Company, Inc. ("Shissler"), a 
subsidiary of LG Corp., became a subsidiary of the Company. 

B.  Basis of Presentation
The consolidated balance sheets as of June 30, 1996 and 1995 include the 
Company and its wholly owned subsidiary, LG Seeds, Inc.  All significant 
intercompany transactions have been eliminated in consolidation.

For the year ended June 30, 1996 ("Fiscal 1996"), the financial statements 
contained herein present twelve months of operations of the Company.

For the year ended June 30, 1995 ("Fiscal 1995"), the financial statements 
contained herein present twelve months of operations of the Company.  
Results for the Scott Seed Division of the Company and other properties sold 
during Fiscal 1995 are included up to the date of their respective 
disposals.

For the year ended June 30, 1994 ("Fiscal 1994"), the financial statements 
contained herein present twelve months of operations of Shissler, plus 
operations of the Company (as it was constituted prior to the Limagrain 
Transaction) from February 1, 1994 (the effective date of the Limagrain 
Transaction) through June 30, 1994.

The preparation of financial statements in conformity with generally 
accepted accounting principles requires management to make estimates and 
assumptions that affect the reported amounts of assets and liabilities and 
related disclosures at the date of the financial statements and the reported 
amount of revenues and expenses during the reporting period. Actual results 
could differ from those estimates.

C.  Revenue Recognition
Sales of seed products are recorded upon shipment, reduced by a reserve for 
estimated returns and discounts.

D.  Research and Development Costs
Although the Company has no significant internal research and development 
effort, it has access to research conducted by LG Corp. and other Limagrain 
affiliates.  The cost of this expertise is paid to LG Corp. in the form of 
royalties on products sold.

E.  Cash and Cash Equivalents
Cash and cash equivalents consist of cash in banks and short-term 
investments with original maturities of three months or less.

F.  Inventories
Inventories consist primarily of seed products and supplies.  Seed product 
inventory is valued at the lower of average cost by crop year or market.  
Supply inventory is valued at the lower of cost (using the first-in, first-
out method) or market. Gains or losses on commodity hedging transactions are 
included as a component of inventory.

G.  Derivatives
The Company has contractual commitments with seed growers for payments based 
on the local commodity prices for soybeans and wheat.  To mitigate the 
impact of fluctuations in commodity prices on inventory costs, the Company 
attempts from time to time to hedge these commitments by using Chicago Board 
of Trade futures contracts for the respective crops.  The Company matches 
these futures contracts to its purchases of inventory, closing out the 
futures contracts as payments are made to the seed growers. Unrealized gains 
and losses on the futures contracts are included in the inventoried seed 
cost of soybeans and wheat. At June 30, 1996, the Company had futures 
contracts for 80,000 bushels of December wheat at prices ranging from $5.75 
to $5.80 per bushel which resulted in a $69,000 unrealized loss included in 
inventory. There were no open futures contracts at June 30, 1995.

H.  Property, Plant and Equipment
Property, plant and equipment are recorded at cost and are depreciated using 
the straight-line method over the estimated useful lives of the assets.  
Depreciable lives for asset classes are:

                      Land improvements                 15 years
                      Buildings and improvements        15 to 32 years
                      Machinery and equipment           7 to 20 years
                      Office equipment and computers    3 to 5 years

I.  Goodwill 
Goodwill arose primarily from the 1994 Limagrain Transaction and is being 
amortized using the straight-line method over a period of 20 years. The 
Company evaluates the existence of goodwill impairment on the basis of 
whether the goodwill is fully recoverable from projected, undiscounted net 
cash flows.
 
J.  Income Taxes
The Company utilizes the asset and liability method of accounting for income 
taxes whereby deferred tax assets and liabilities are recognized for the 
future tax consequences attributable to differences between the financial 
statement carrying amounts of existing assets and liabilities and their 
respective tax bases.  Deferred tax assets and liabilities are measured 
using enacted tax rates expected to apply to taxable income in the years in 
which those temporary differences are expected to be recovered or settled. 
The effect on deferred tax assets and liabilities of a change in tax rates 
is recognized in income in the period that includes the enactment date.

The Company files a Federal consolidated tax return with other corporations 
controlled by LG Corp. The related tax sharing agreement provides that 
consolidated Federal income tax is allocated among profitable companies.  
Companies with operating losses receive benefits in the future by 
effectively offsetting taxable income against prior operating losses.

K.  Loss Per Common Share
Loss per common share is computed based on the weighted average of all 
classes of common shares outstanding during the period after taking into 
account the amount of cumulative Preferred Stock dividends, whether or not 
declared.

The weighted average number of shares outstanding for the year ended June 
30, 1994 reflects seven months of historical Shissler shares (5,000 shares 
converted to 97,777,178 shares computed by applying the exchange ratio of 
19,555.44 shares of Company stock to each share of Shissler stock) and five 
months of shares since the exchange (121,000,000).

L.  Fair Value of Financial Instruments
Carrying amounts of cash, accounts receivable, accounts payable and accrued 
liabilities approximate fair value because of the short maturity of these 
financial instruments.  The Company's borrowings under its Line of Credit 
are at variable interest rates tied to market rates and, accordingly, the 
Company considers the fair value to be the same as the carrying value.

M.  Reclassification of Financial Statements
Certain amounts in the Fiscal 1995 and Fiscal 1994 financial statements have 
been reclassified to conform with the current year presentation. 
Specifically, Warehouse and distribution expenses were reclassified from 
sales and marketing expense. Gain on disposition of fixed assets, 
miscellaneous taxes, and finance charge income have been moved from general 
and administrative expense to the other income (expense) section of the 
Statements of Operations.

N.  Advertising
The Company expenses all advertising in the period incurred.

2.  INVENTORIES

Inventories at June 30, 1996 and 1995 are as follows:

                                                   (in thousands of dollars)
                                                     1996               1995

     Finished seed                                $ 3,599            $ 4,243
     Unfinished seed                                1,630              2,123
     Supplies and other                               747                561
                                                  -------            -------
        Total inventories                         $ 5,976            $ 6,927
                                                  =======            =======

"Finished seed" consists of bagged product, ready for sale, net of reserves 
for obsolescence.  "Unfinished seed" consists of bulk product not yet bagged 
and the cost associated with the seed crop planted in the spring of the 
applicable fiscal year.  "Supplies and other" consists of foundation seed, 
unused bags, pallets and other supply items.

3.  PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment at June 30, 1996 and 1995 are as follows:

                                                  (in thousands of dollars)
                                                    1996               1995

     Land and improvements                       $   793            $   793
     Buildings and improvements                    7,395              8,109
     Machinery and equipment                       4,186              4,274
     Construction in progress                      1,437                105
                                                 -------            -------
                                                 $13,811            $13,281
     Less accumulated depreciation                (4,089)            (3,510)
                                                  -------            -------
       Net property, plant and equipment         $ 9,722            $ 9,771
                                                 ========           ======= 

4.  FIRE AT ELMWOOD, ILLINOIS PRODUCTION FACILITY

During Fiscal 1996, fire destroyed the building used for the treating and 
grading of corn and soybeans at the Company's Elmwood, Illinois facility.  
The Company received $1,029,000 in insurance proceeds as a result of this 
fire.  The net book value of this building was $646,000.  The resulting gain 
of $383,000 is classified as part of gain on disposition of fixed assets.

The Company has entered into a contract to replace this destroyed building 
with a new, modern grading and treating building with a total projected cost 
of $1,881,000.  As of June 30, 1996, $1,383,000 had been spent and is 
included in the construction in progress account.

5.  GOODWILL AND OTHER ASSETS

Goodwill and other assets (at cost, less accumulated amortization of 
$1,175,000 and $676,000 at June 30, 1996 and 1995, respectively) are set 
forth in the following table.  Goodwill arose primarily from the Limagrain 
Transaction.
                                                   (in thousands of dollars)
                                                      1996              1995

     Goodwill (net of amortization)               $  8,791           $ 9,290
     Deposits and other                                157               232
                                                  --------           -------
                                                  $  8,948           $ 9,522
                                                  ========           =======
6.  LINE OF CREDIT AND NOTE PAYABLE

The Company has a revolving credit arrangement with its principal bank 
whereby the Company can borrow up to $12,000,000 based on a borrowing base 
formula and subject to certain limitations in availability contained in the 
Limagrain Agreement.  This line of credit, which expires December 1, 1996, 
bears interest (at the Company's option) based on either (i) the Bank Prime
Loan rate, (ii) the London Interbank Offered Rate ("LIBOR") index or (iii) the 
Bank Offered Rate.  Borrowings under this line of credit are secured by the 
inventory and accounts receivable of the Company and its subsidiary and by 
the guarantees of Limagrain and LG Corp.  The maximum and average amounts 
outstanding under this line of credit during the year ended June 30, 1996 
were $9,600,000 and $6,762,000, respectively.  The weighted average interest 
rate during Fiscal 1996 was 6.81%.

The Company also has a note payable to non-affiliates of $138,000 at June 
30, 1996. This note bears interest at an annual rate of 9% and is payable 
through September 1997.

The annual maturities of the other note payable are as follows:

                                                  (in thousands of dollars)
                                                   Year             Amount
                                                   1997             $  107
                                                   1998                 31
                                                                    ------
                                                                    $  138
                                                                    ======
7.  DUE TO AFFILIATES

Amounts due to affiliates at June 30, 1996 and 1995 were comprised as 
follows:

                                                  (in thousands of dollars)
                                                    1996               1995

  Promissory note dated June 30, 1995            $    --            $ 3,261  
  Promissory note dated June 30, 1996              3,261                 --
  Promissory note dated December 1, 1994              --              2,000
  Other long-term payable                             --                 65
  Promissory note dated June 27, 1996              2,000                 --
  Current amounts due to affiliates                  175                 --   
                                                 -------            -------
                                                 $ 5,436            $ 5,326
                                                 =======            =======
On June 30, 1995, the Company executed a promissory note in the amount of 
$3,261,000 payable to LG Corp.  This note is subordinate to the Company's 
line of credit and had an initial term of two years.  Interest is due 
annually and is set each period (July 1 through June 30 of the following 
year) based on the one-year LIBOR on July 1 plus .4375%.  During Fiscal 
1996, the maturity of this note was extended to July 1, 1998.

On December 1, 1994, the Company executed a promissory note in the amount of 
$2,000,000 payable to LG Corp. On November 30, 1995, the note was retired in 
exchange for 200,000 shares of the Company's Class A Preferred Stock. 

On June 27, 1996, the Company executed a promissory note in the amount of 
$2,000,000 payable to an affiliated company. The term of the note is 68 days 
with interest to be paid at maturity based on LIBOR plus .50%.

Other current amounts due to affiliates result from amounts due for services 
rendered under various contracts. 

8.  CAPITAL STOCK

Authorized shares of stock include: 150,000,000 shares of common stock; 
11,100,000 shares of Class A common; 11,100,000 shares of Class B common; 
and 2,000,000 shares of Class A Preferred.

On December 1, 1994, LG Corp. converted the $4,000,000 advanced to the 
Company into (i) a long-term note for $2,000,000 bearing interest at LIBOR 
plus 1.15%, and (ii) $2,000,000 in Class A Preferred Stock of the Company.  

On November 30, 1994, State Farm Automobile Insurance Company ("State Farm") 
converted 4,698,336 shares of Class A common stock and 4,807,533 shares of 
Class B common stock of the Company into 9,505,869 shares of common stock.  
This conversion was available to State Farm at their option under the 
conditions of the Class A and Class B common stock.  This transaction had no 
effect on the net outstanding, fully diluted shares of the Company, or on 
the relative equity of any shareholder.

On June 26, 1995, State Farm sold 6,054,751 shares of Class A common stock 
back to the Company at par value (i.e., $0.01 per share).  This represented 
approximately 5% of the outstanding shares of the Company.  The price of 
$0.01 is substantially below the current market price and the net book value 
per share.  The result of this transaction was to increase the equity 
position of all remaining shareholders by approximately 5%. 

On November 30, 1995, the Company retired the long-term note of $2,000,000 
described above in exchange for $2,000,000 of the Company's Class A 
Preferred Stock.

As of June 30, 1996, there are only two classes of stock issued and 
outstanding:  common stock and Class A Preferred Stock.

The Class A Preferred Stock of the Company (all of which is owned by LG 
Corp.) pays a cumulative dividend of $.75 per share per year when declared 
by the Board of Directors.  No such dividend has been declared by the Board 
of Directors.  Pursuant to the terms and conditions of the Company's Class A 
Preferred Stock, should any dividend be declared or paid on the common stock 
of the Company, the holders of Class A Preferred Stock would be entitled to 
receive dividends at a rate per share equal to that of the common stock.  

As of June 30, 1996 and 1995, the cumulative amount of undeclared dividends 
on the Class A Preferred Stock was $1,075,000 and $462,500, respectively.

9.  STOCK OPTION PLAN

The Company has reserved 1,500,000 shares of common stock for issuance under 
an incentive stock option plan (the "1992 Plan").  Incentive stock options 
granted under the 1992 Plan are exercisable in installments following a 
minimum period of employment but expire within ten years from the date of 
grant.  Additionally, the 1992 Plan permits the Company to issue 
nonqualified stock options.  As of June 30, 1996 and 1995, the Company had 
1,140,000 shares available under the 1992 Plan for the grant of options to 
eligible employees.  Subsequent to the Limagrain Transaction, there have 
been no additional grants under the 1992 Plan.

The 1992 Plan also permits the Company to issue tandem stock appreciation 
rights that permit the recipient to exchange an option for an amount of 
stock and/or cash equal to the increase in the value of the common stock 
from the date of the grant to the date of its exercise.  No such awards have 
been granted.

During Fiscal 1996, all outstanding options were either (i) repurchased by 
the Company or (ii) determined to have expired. See RELATED PARTY 
TRANSACTIONS.  The repurchase on expiration of these options resulted in a 
reduction of administrative expense of $150,000 during Fiscal 1996.

The following table summarizes options granted, exercised and outstanding 
for the two years ended June 30, 1996:
                                                                                
                                                                   Price
                                Outstanding       Exercisable      Range

Options as of June 30, 1994        386,239          317,239     $1.31-$5.50

Granted                               --               --
Canceled                          (145,614)         (85,614)    $1.75-$5.33
Exercised                             --               --
Vested                                --              3,000     $1.75
                                  ---------        ---------
Options as of June 30, 1995        240,625          234,625     $1.31-$5.50

Canceled                          (240,625)        (234,625)    $1.31-$5.50
                                  ----------       --------- 
Options as of June 30, 1996           --               --          --   
                                  ==========       =========
10.  PENSION PLAN

Substantially all full-time employees of the former Shissler subsidiary were 
covered under a defined benefit pension plan (the "Plan") sponsored by an 
affiliate.  The Plan provided benefits based on years of service and the 
employee's compensation during the last five years of employment.  Plan 
assets were primarily invested in pooled equity and fixed income funds and  
managed by a life insurance company.  The Company's funding policy was to 
contribute annually an amount that is not less than the Employee Retirement 
Income Security Act of 1974 minimum funding requirement and not in excess of 
the amount that could be deducted for Federal income tax purposes.  
Effective December 31, 1995, the Company elected to cease participation in 
the Plan. At that time (i) all covered employees became fully vested, (ii) 
the Company entered into an agreement with the sponsoring affiliate whereby  
the Company ceases to be a participating employer in the Plan and (iii) the 
Company established a defined contribution plan covering all regular full 
time employees. The Company has no obligation for future benefits under the 
Plan. The following table sets forth the Company's portion of the Plan's 
funded status and amounts recognized in the Company's balance sheet at June 
30, 1995:
 
                                                   (in thousands of dollars)
Actuarial present value of benefit obligations:
  Vested benefit obligation                                    $116            
  Accumulated benefit obligation                                134    
Projected benefit obligation for service
   rendered to date                                             264
Plan assets at fair value                                       225  
                                                               -----
Projected benefit obligation in excess of
   Plan assets                                                   39
Unrecognized net gain                                           (39)
                                                               -----
Prepaid pension cost                                           $ --
                                                               =====

Net pension cost for Fiscal 1996, 1995 and 1994 included the following 
components:

                                             (in thousands of dollars)  
                                       1996            1995            1994
Service cost of benefits earned
 during the period                     $ 32            $ 24            $ 27     
Interest cost on projected benefit
 obligation                              --              43              45
Actual return on plan assets             --             (42)            (42)    
Net amortization and deferral            --              --               1
                                       -----           -----           -----
  Net pension cost                     $ 32            $ 25            $ 31
                                       =====           =====           =====

Assumptions used in accounting for the Plan as of June 30, 1995 and 1994 
were:

                                                  1995                1994

Discount rate                                     7.75%               7.75%
Rate of increase in compensation levels           6.00%               6.00%
Expected long-term rate of return on assets       8.00%               8.00%

11.  INCOME TAXES

Prior to June 30, 1995 LG Corp. had filed its tax return on a November 30 
fiscal year.  Effective June 30, 1995, LG Corp. elected to file its tax 
returns on a fiscal year ending June 30 to coincide with the fiscal period 
used by the Company for financial reporting purposes.

On June 30, 1996 and 1995, the Company had pre-acquisition net operating 
loss carryforwards of approximately $1,632,000 and $1,768,000, respectively, 
which expire at a rate of $136,000 per year through 2008. The Company had 
post-acquisition net operating loss carryforwards of approximately 
$12,593,000 and $9,832,000 on June 30, 1996 and 1995, respectively, which 
expire through 2011. (Refer to footnote 1.J--SUMMARY OF SIGNIFICANT 
ACCOUNTING POLICIES--INCOME TAXES)

The components of income tax expense are as follows:

                                            (thousands of dollars)
                                     1996              1995           1994 
                
  Federal                            $(28)             $ 28           $ --      
  State                                13                39             --      
                                     -----             ----           ----
  Total                              $(15)             $ 67           $ --
                                     =====             ====           ====
The actual income tax benefit differed from the expected income tax benefit 
(computed by applying the applicable U.S. Federal corporate income tax rate 
of 34% to loss before income taxes) as follows: 
        
                                              (thousands of dollars)
                                      1996              1995           1994

Computed "expected" tax benefit      $(933)            $(814)         $(322)
State income taxes, net of 
   Federal benefit                       9                25             --
Alternative minimum tax                (28)               28             --
Other                                   --                --             --
Net operating loss carryforward        937               828            322
                                     ------             -----          -----   
   Total                             $ (15)             $ 67           $ --
                                     ======             =====          =====

The tax effects of temporary differences that give rise to significant 
portions of the deferred tax assets and liabilities at June 30, 1996 and 
1995 are presented below.

                                                   (in thousands of dollars)
                                                     1996            1995

Deferred tax assets:
  Net operating loss carryforward
   (Pre-acquisition)                               $  636          $  689
  Net operating loss carryforward
   (Post-acquisition)                               4,911           3,834 
  Allowance for bad debts                              35              48
  Allowance inventory valuation                        74             270
  Accrued compensation, sales allowances
   and other expenses                                 336             202
                                                   -------         -------
       Total gross deferred tax assets             $5,992          $5,043
       Less:  valuation allowance                  (5,324)         (4,307)
                                                   -------         -------
  Total deferred tax assets                        $  668          $  736

Deferred tax liability:
  Difference between net value of fixed
   assets for book and tax purposes                  (668)           (736)
                                                   -------         -------
  Net deferred tax assets                          $   --          $   --    
                                                   =======         =======
                                  
The change in the deferred tax valuation allowance was an increase of 
$1,017,000 in Fiscal 1996 compared to an increase of $3,172,000 in Fiscal 
1995, and an increase of $394,000 in Fiscal 1994.

Subsequently recognized tax benefits relating to the valuation allowance at 
the date of the Limagrain Transaction (see Note 1.A--BUSINESS) will be 
allocated to goodwill.  At June 30, 1996, the amount of valuation allowance 
potentially applicable to goodwill aggregated $636,000.

12.  COMMITMENTS

The Company leases office space and certain equipment under non-cancelable 
operating leases which expire through 2000.  Rental expenses charged to 
operations were $465,000, $476,000 and $349,000 for the years ended June 30, 
1996, 1995 and 1994, respectively.  Future annual minimum rentals are 
$183,000, $113,000, $82,000, $19,000 and $0, for Fiscal 1997 through 2001, 
respectively.

13.  RELATED PARTIES

The Company has access to the research conducted by LG Corp.  The cost of 
this expertise is paid to LG Corp. as royalties on corn units sold.  Costs 
incurred were approximately $94,000, $81,000 and $78,000  for Fiscal 1996, 
1995 and 1994, respectively.  In addition, the Company paid $50,000, $35,000 
and $0 to Callahan (a division of LG Corp.) for royalties on soybean 
genetics for Fiscal 1996, 1995 and 1994, respectively.

The Company has agreements with affiliated companies that provide for 
certain administrative and management services.  Combined costs incurred 
under these agreements were $320,000, $320,000 and $305,000 for Fiscal 1996, 
1995 and 1994, respectively.  Fees for these arrangements are negotiated 
annually by management and approved by the Board of Directors.

The Company sells seed to various affiliated companies in Europe primarily 
under production contracts.  These contracts are negotiated annually and are 
based on arms-length negotiated pricing and in quantities determined by the 
affiliates' requirements.  Export sales to affiliates amounted to $1,489,000 
for Fiscal 1996, $3,089,000 for Fiscal 1995 and $1,582,000 for Fiscal 1994.

During Fiscal 1996 the Company repurchased 70,000 stock options from 
officers and directors for $3,400. The repurchase of the options, with 
exercise prices between $1.31 and $3.50 per share, resulted in a reduction 
of approximately $66,000 in long-term liabilities.  The net result was a 
reduction of general and administrative expenses of $62,000.

14. SUPPLEMENTAL CASH FLOW INFORMATION

Cash paid for interest aggregated approximately $728,000, $687,000, and 
$493,000 for Fiscal 1996, 1995, and 1994, respectively.

In connection with the sale of various assets during Fiscal 1995, the 
Company received cash of $647,000 and non-operating receivables of $722,000.  
The net book value of assets sold was $1,780,000.

15.  LIQUIDITY

The Company has incurred net operating losses and negative cash flow from 
operations for Fiscal 1996, 1995, and 1994.  The Company's current line of 
credit expires on December 1, 1996, at which time management expects to 
renew this credit facility.

Management believes that the Company's operations will begin to generate 
positive cash flows as a result of the restructuring and redirection of its 
marketing, production, and administrative functions.  In the event that 
additional financial support is required, management believes there is a 
strong commitment by Limagrain to enable the Company to obtain sufficient 
working capital to support the business.  Management's belief that 
Limagrain's support will continue is based on Limagrain's commitment under 
the Line of Credit guarantee, the additional contribution of $9,000,000 for 
Preferred Stock, and the advance of $3,261,000 in long-term borrowing.

16.  OTHER INCOME AND EXPENSE

Included in other income and expense for Fiscal 1996 is $94,000 of gain on 
the disposal of AgriBioTech, Inc. common stock received during Fiscal 1995 
by the Company as part of the proceeds from the disposal of its Scott Seed 
Company operations.  Also included here are $68,000, $133,000, and $51,000 
in finance charge income on customer accounts for Fiscal 1996, 1995, and 
1994, respectively.
<TABLE>


                       BIOTECHNICA INTERNATIONAL, INC.
                    VALUATION AND QUALIFICATION ACCOUNTS
                 Years ended June 30, 1996, 1995 and 1994
                               Schedule II
                        (in thousands of dollars)  


                      Balance      Charged to                     Balance 
                     at July 1,    Costs and                     at June 30,  
                      1993         Expenses     Other  Deductions   1994
<CAPTION>
<S>                    <C>         <C>          <C>     <C>          <C>

Allowance for doubtful
accounts               $    19      $    80     $338*   $ (66)**     $371

Accumulated amortization:
  Goodwill                   6          191       --        --        197
  Non-compete agreement     47            3       --        --         50
                       -------      -------     ----     -----       ----
                       $    53      $   194     $ --     $  --       $247
                       =======      =======     ====     =====       ====


                       Balance      Charged to                    Balance
                      at July 1,    Costs and                    at June 30,  
                       1994         Expenses    Other  Deductions   1995
 

Allowance for doubtful
accounts               $   371     $   173      $ --     $(421)**     $ 123

Accumulated amortization:
  Goodwill                 197         479        --        --          676
  Non-compete agreement     50          --        --       (50)          --
                       -------     -------      ----     ------       -----
                       $   247     $   479      $ --     $ (50)       $ 676
                       =======     =======      ====     ======       =====


                        Balance      Charged to                   Balance
                       at July 1,    Costs and                   at June 30,  
                        1995         Expenses    Other Deductions   1996


Allowance for doubtful 
accounts               $   123     $    --      $ --    $ (33)**      $   90

Accumulated amortization: 
  Goodwill             $   676     $   499      $ --    $  --         $1,175


 *Balance received as part of the reverse acquisition accounting for 
  Limagrain Transaction
 **Write-off of uncollectible accounts receivable
</TABLE>

ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND 
FINANCIAL DISCLOSURE

None.


PART III

ITEM 10.  DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

The information set forth under the captions "INFORMATION ABOUT EXECUTIVE 
OFFICERS" and "PROPOSAL 1:  ELECTION OF DIRECTORS" in the Company's Proxy 
Statement for the Annual Meeting of Shareholders to be held on November 12, 
1996 (the "1996 Proxy Statement") is incorporated herein by reference.


ITEM 11.  EXECUTIVE COMPENSATION

The information set forth under the captions "EXECUTIVE COMPENSATION," 
"PROPOSAL 1:  ELECTION OF DIRECTORS," "REPORT OF THE COMPENSATION COMMITTEE 
OF THE BOARD OF DIRECTORS ON EXECUTIVE COMPENSATION," and "STOCK PERFORMANCE 
GRAPH" in the Company's 1996 Proxy Statement are incorporated herein by 
reference.


ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The information set forth under the captions "SECURITY OWNERSHIP OF CERTAIN 
BENEFICIAL OWNERS" and "SECURITY OWNERSHIP OF MANAGEMENT" in the Company's 
1996 Proxy Statement is incorporated herein by reference.


ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

The information set forth under the caption "CERTAIN RELATIONSHIPS AND OTHER 
RELATED TRANSACTIONS" in the Company's 1996 Proxy Statement is incorporated 
herein by reference.



PART IV

ITEM 14.  EXHIBITS, FINANCIAL STATEMENT SCHEDULE AND REPORTS ON FORM 8-K

(a)  Financial Statements, Financial Statement Schedule and Exhibits

     1.  Financial Statements.  See Item 8 for the financial statements of    
         the Company filed as part hereof.

     2.  Financial Statement Schedule.  See Item 8 for the financial 	   
         statement schedule of the Company filed as part hereof.

     3.  Exhibits.  The exhibits listed in the following index are 	         
         incorporated herein by reference.

Exhibit No. 	Description of Exhibit

  2.1     Credit Enhancement and Reorganization Agreement among the Company, 
Groupe Limagrain Holding S.A., and Limagrain Genetics Corp. dated as of 
October 26, 1993 (incorporated by reference to Exhibit 2.1 to Form 8-K filed 
with the Commission November 10, 1993, File No. 0-11854).

  2.2     Amendment to Credit Enhancement and Reorganization Agreement dated 
December 10, 1993, among the Company, Groupe Limagrain Holding S.A., and 
Limagrain Genetics Corp. (incorporated by reference to Exhibit 1 to Form 8-K 
filed with the Commission December 16, 1993, File No. 0-11854).

  3.1  Amended and Restated Certificate of Incorporation dated March 7, 
1994, of the Company, as amended on June 28, 1994 (incorporated by reference 
to Exhibit 3.1 to Form 10-K filed with the Commission on October 13, 1994, 
File No. 0-11854).

  3.2  By-laws of the Company, as amended on October 29, 1983, May 7, 1987 
and May 18, 1994 (incorporated by reference to Exhibit 3.2 to Form 10-K 
filed with the Commission on October 13, 1994, File No. 0-11854).


Exhibit No. 	Description of Exhibit 

  4.1  Specimen Certificate of Common Stock of the Company (incorporated by 
reference to Exhibit 4(A) to the Company's Annual Report on Form 10-K filed 
with the Commission on March 31, 1986, File No. 0-11854).			

  4.8  Specimen Certificate of Class A Preferred Stock of the Company 
(incorporated by reference to Exhibit 4.8 to Form 10-K filed with the 
Commission on October 13, 1994, File No. 0-11854).

  4.9  Certificate of Designations (incorporated by reference to Exhibit 4.9 
to Form 10-K filed with the Commission on October 13, 1994, File No. 0-11854).

 10.1  The Company's 1982 Incentive Stock Option Plan adopted on July 30, 
1982, as amended on January 31, 1987, on May 7, 1987, and on May 11, 1989 
(incorporated by reference to Exhibit 10.1 to Form 10-K filed with the 
Commission on March 29, 1990, File No. 0-11854).

 10.2  The Company's 1992 Stock Incentive Plan adopted on May 7, 1992, as 
amended on May 18, 1994 (incorporated by reference to Exhibit 10.2 to Form 
10-K filed with the Commission on October 13, 1994, File No. 0-11854).

 10.3  Secured Revolving Credit Agreement dated October 26, 1993,between 
Harris Trust and Savings Bank and the Company (incorporated by reference to 
Exhibit 10.31 to Form 10-K filed with the Commission on November 15, 1993, 
File No. 0-11854).

 10.11 First Amendment to Secured Revolving Credit Agreement between Harris 
Trust and Savings Bank and the Company dated as of February 15, 1994 
(incorporated by reference to Exhibit 10.39 to Form 10-K filed with the 
Commission on October 13, 1994, File No. 0-11854).

 10.12 Second Amendment to Secured Revolving Credit Agreement between Harris 
Trust and Savings Bank and the Company dated March 7, 1994 (incorporated by 
reference to Exhibit 10.40 to Form 10-K filed with the Commission on October 
13, 1994, File No. 0-11854).

 10.13 Debt Subordination Agreement between Harris Trust and Savings Bank 
and the Company dated June 29, 1994 (incorporated by reference to Exhibit 
10.42 to Form 10-K filed with the Commission on October 13, 1994, File No. 
0-11854).

 10.14 Debt Restructuring Agreement by and among Limagrain Genetics Corp., 
Shissler Seed Co., Inc., Limagrain Holding S.A. and the Company dated June 
29, 1994 (incorporated by reference to Exhibit 10.43 to Form 10-K filed with 
the Commission October 13, 1994, File No. 0-11854).

 10.16 Remuneration Individuelle Sur Objectifs Cadres Associes (Individual 
Compensation and Performance Objectives for Associate Level Employees) for 
J.C. Gouache dated October 4, 1995, amended February 9, 1996.*/**

 10.17 Remuneration Individuelle Sur Objectifs Cadres Associes (Individual 
Compensation and Performance Objectives for Associate Level Employees) for 
Bruno Carette dated October 4, 1995, amended February 9, 1996.*/**

 10.18 Letter Amendment to Consulting Agreement between the Company and 
William C. Hittinger dated December 8, 1995.*

 10.19 Letter Amendment to Consulting Agreement between the Company and 
Ralph W.F. Hardy dated January 8, 1996.* 

 10.26 Promissory note issued to LG Corp. by the Company dated June 29, 1995 
(incorporated by reference to Exhibit 10.27 to Form 10-K filed with the 
Commission on September 22, 1995, File No. 0-11854).

 10.27 Promissory note issued to LG Corp. by the Company dated June 30, 
1996.*

 10.29 Service Agreement between LG Seeds, Inc. and Limagrain Innovations 
dated July 1, 1994 (incorporated by reference to Exhibit 10.29 to Form 10-K 
filed with the Commission September 22, 1995, File No. 0-11854).

 10.30 Amendment 2 to Exhibit A, dated July 1, 1996, to Service Agreement 
between LG Seeds, Inc. and Limagrain Innovations dated July 1, 1994.*

 10.31 Biotechnology Service Agreement between LG Seeds, Inc. and BIOCEM 
S.A. dated July 1, 1994 (incorporated by reference to Exhibit 10.30 to Form 
10-K filed with the Commission on September 22, 1995, File No. 0-11854).
		

 10.32 Amendment 2 to Exhibit A dated July 1, 1996 to Biotechnology Service 
Agreement between LG Seeds, Inc. and BIOCEM S.A. dated July 1, 1994.*

 10.33 Service Agreement between LG Seeds, Inc. and Limagrain Genetics 
International S.A. dated July 1, 1994 (incorporated by reference to Exhibit 
10.31 to Form 10-K filed with the Commission on September 22, 1995, File No. 
0-11854).

 10.34 Amendment 2 to Exhibit A dated July 1, 1996 to Service Agreement 
between LG Seeds, Inc. and Limagrain Genetics International S.A. dated July 
1, 1994.*

 10.35 Tax Allocation Agreement among the Limagrain Affiliated U.S. 
corporations filing a consolidated tax return with Limagrain Genetics 
Corporation (incorporated by reference to Exhibit 10.32 to Form 10-K filed 
with the Commission September 22, 1995, File No. 0-11854).

 10.36 Option Buyout Agreement between Ralph W.F. Hardy and the Company 
dated June 10, 1996.*

 10.37 Option Buyout Agreement between William C. Hittinger and the Company 
dated May 8, 1996.*

 10.38 Option Buyout Agreement between Larry D. Rieffel and the Company 
dated May 6, 1996.*

 21.00 Subsidiaries of the Company.*

 27.00 Financial Data Schedule.*

(b)  Reports on Form 8-K.

	Current report on Form 8-K dated March 29, 1996, Filed Number 0-11854, 
was filed in connection with a change in officers of the Corporation.

     (*)Filed herewith.
    (**)Management contract filed pursuant to Item 14(c) of Form 10-K.


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities 
Exchange Act of 1934, the Company has duly caused this report to be signed 
on its behalf by the undersigned, thereunto duly authorized.
                          			BIOTECHNICA INTERNATIONAL, INC.

                            			By:  /s/Jean Ferrand
                                 			 Jean Ferrand
                                 			 Chairman, Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this 
report has been signed below by the following persons on behalf of the 
Company and in the capacities and on the dates indicated.

    Signature                    Title                           Date

/s/ Jean Ferrand          Chairman, Director             September 4, 1996      
    Jean Ferrand

/s/ Emmanuel Rougier      Chief Executive Officer,
    Emmanuel Rougier      Director                       September 4, 1996

/s/ Bruno Carette         President and                   
    Bruno Carette         Chief Operating Officer        September 4, 1996 

/s/ Edward M. Germain     Chief Financial Officer        September 4, 1996 
    Edward M. Germain                 

/s/ Philip M. Nordeen     Chief Accounting Officer       September 4, 1996
    Philip M. Nordeen

/s/ Claude Agier          Director                       September 4, 1996     
    Claude Agier

/s/ George R. Allbritten  Director                       September 4, 1996
    George R. Allbritten

/s/ Ralph W.F. Hardy      Director                       September 4, 1996      
    Ralph W.F. Hardy

/s/ William C. Hittinger  Director                       September 4, 1996     
    William C. Hittinger

/s/ Laurent Petoton       Director                       September 4, 1996      
    Laurent Petoton



                              CORPORATE INFORMATION



SHAREHOLDER REFERENCE                            EXECUTIVE OFFICERS

CORPORATE HEADQUARTERS                           Bruno Carette
BioTechnica International, Inc.                  President and Chief 
Operating Officer
4001 War Memorial Drive
Peoria, IL  61614                                Edward M. Germain
(309) 681-0300                                   Vice President, Secretary
                                                 and Chief Financial Officer
OPERATING SUBSIDIARY
LG Seeds, Inc.                                   Larry D. Rieffel
4001 War Memorial Drive                          Vice President, Production 
Peoria, IL  61614                                and Logistics

                      				  		                   Philip M. Nordeen	             
                                                 Chief Accounting Officer 
                                                 and Treasurer
TRANSFER AGENTS
American Stock Transfer &                        BOARD OF DIRECTORS
  Trust Company
40 Wall Street                                   Jean Ferrand
New York, NY  10005                              Chairman of the Board
(212) 936-5100
                                                 Emmanuel Rougier
AUDITORS                                         Chief Executive Officer
KPMG Peat Marwick L.L.P.
Chicago, IL  60601                               George R. Allbritten

COUNSEL                                          Claude Agier    
Shook, Hardy & Bacon L.L.P.
Kansas City, MO  64106                           Ralph W. F. Hardy   

SEC FORM 10-K                                    William C. Hittinger
A copy of the Company's annual report
to the Securities and Exchange                   Laurent Petoton
Commission on Form 10-K is available 
without charge upon written request          
to:

Shareholder Relations
BioTechnica International, Inc.
4001 War Memorial Drive
Peoria, IL  61614

ANNUAL MEETING
The annual meeting of shareholders will
be held at 10:00 A.M. on Tuesday,
November 12, 1996 at The Signature Inn,
4112 North Brandywine, Peoria, IL.


Exhibit 10.16


EXECUTIVE COMPENSATION AGREEMENT
1995/96

EXECUTIVE: J.C. GOUACHE                      MANAGER:  Emmanuel ROUGIER

The EXECUTIVE compensation plan is based on two components:

  -- a salary, aligned with market information
  -- a bonus linked to the accomplishments of specific, quantifiable 
objectives.

The agreement between the EXECUTIVE and his MANAGER determines the 
salary and objectives for the year ended June 30, 1996 ("Fiscal 1996").

At the end of this period, the parties concerned will decide on the 
continuation of the process.

I.  SALARY

    Starting October 1, 1995, the EXECUTIVE'S annual gross salary will 
be: 595,280 French Francs

    It will be in effect for a period of 12 months, except in the event 
of a change in job function.

II. BONUS

    For the period from July 1, 1995 to June 30, 1996, the objectives 
and relevant bonuses for the EXECUTIVE are noted hereafter.

    1.	Increase in CAF of Limagrain Genetics International compared 
to actual results for Fiscal 1995

	40,000 French Francs multiplied by [CAF for Fiscal 1996 less 
60,225K French Francs] divided by 15,000K French Francs

    2.	Increase in net sales of BioTechnica/LG Seeds compared to 
proforma results for Fiscal 1995

	20,000 French Francs multiplied by [Net Sales of LG Seeds for 
Fiscal 1996 less $23,961,000] divided by $1,000,000

    3.	Improvement of CAF of BioTechnica/LG Seeds for Fiscal 1996

 If CAF is equal to or less than a negative $1,870,000, bonus will be $0

 If CAF is greater than a negative $1,870,000, bonus will be 
CAF96+$1,870,000 divided by $1,600,000, times 20,000 French Francs

NOTE:	CAF is a French accounting measurement of cash generated by 
operations.  It is equal to net income plus depreciation and 
amortization, adjusted by changes in inventory reserves, accounts 
receivable reserves, and gain or loss on disposal of fixed assets.

Payment of these bonuses is conditional upon the completion of the 
objectives as determined by the MANAGER and the EXECUTIVE for Fiscal 
1996.  Each objective will be analyzed separately during a meeting 
between the EXECUTIVE and his MANAGER.

I understand and agree with the compensation plan as outlined above.  I 
have retained a signed copy of this agreement for my records.


Executed in Duplicate


/s/ Emmanuel ROUGIER                             /s/ J. C. GOUACHE
        MANAGER                                         EXECUTIVE



Dated:  October 4, 1995
        Amended February 9, 1996


Exhibit 10.17

                      EXECUTIVE COMPENSATION AGREEMENT
                                  1995/96

EXECUTIVE:  B. CARETTE                    MANAGER:  J.C. GOUACHE

The EXECUTIVE compensation plan is based on two components:

  -- a salary, aligned with market information
  -- a bonus linked to the accomplishments of specific, quantifiable 
objectives

The agreement between the EXECUTIVE and his MANAGER determines the 
salary and objectives for the year ended June 30, 1996 ("Fiscal 1996").

At the end of this period, the parties concerned will decide on the 
continuation of the process.

 I.  SALARY
     Starting October 1, 1995, the EXECUTIVE'S annual gross salary will 
be:  $80,500.

     It will be in effect for a period of 12 months, except in the event 
of a change in job function.

II.  BONUS
     For the period from July 1, 1995 to June 30, 1996, the objectives 
and relevant bonuses for the EXECUTIVE are noted hereafter.

     1.  Increase in net sales of BioTechnica/LG Seeds compared to 
proforma results for Fiscal 1995.  If net sales are less than 
$23,961,000, bonus will be $0.  If net sales exceed $23,961,000, bonus 
will be $3,500 multiplied by (net sales of LG Seeds for Fiscal 1996 less 
$23,961,000) divided by $1,000,000.

     2.  Improvement of CAF of BioTechnica/LG Seeds for Fiscal 1996

         -- If CAF is equal to or less than a negative $1,870,000, bonus 
will be $0
         -- If CAF is greater than a negative $1,870,00, bonus will be  
CAF96+$1,870,000, divided by $1,600,000, times $3,500

     3.  Domestic Retail Sales Increase (DRS) -- per final audited 
income statement, domestic sales minus wholesale sales
         3.11  If DRS are less than $17,250,000             $0
         3.12  If DRS exceeds $17,250,000:
LGS DRS - $17,250,000, divided by $5,000,000, times $6,500 Bonus

     4.  Domestic Corn Volume Increase (DCV) -- corn volume in number of 
bags (excluding plot, replant)
         4.11  If DCV is less than 160,000 bags             $0
         4.12  If DCV exceeds 160,000 bags
DCV - 160,000 bags , divided by 30,000 bags, times $6,500  Bonus
                              

NOTE:  CAF is a French accounting measurement of cash generated by 
operations.  It is equal to net income plus depreciation and 
amortization, adjusted by changes in inventory reserves, accounts 
receivable reserves, and gain or loss on disposal of fixed assets.

Payment of these bonuses is conditional upon the completion of the 
objectives as determined by the MANAGER and the EXECUTIVE for Fiscal 
1996.  Each objective will be analyzed separately during a meeting 
between the EXECUTIVE and his MANAGER.

I understand and agree with the compensation plan as outlined above.  I 
have retained a signed copy of this agreement for my records.

Executed in Duplicate

/s/  J.C. GOUACHE                      /s/  B. CARETTE
       MANAGER                              EXECUTIVE


Dated:  October 4, 1995
        Amended February 9, 1996



Exhibit 10.27


BIOTECHNICA INTERNATIONAL, INC.
PROMISSORY NOTE


For value received, BioTechnica International, Inc., a Delaware 
Corporation, promises to pay to Limagrain Genetics Corp., a Delaware 
Corporation, the sum of three million, two hundred sixty thousand, eight 
hundred and forty six ($3,260,846) U.S. Dollars.

This note replaces and supersedes the note in the same face amount dated 
June 30, 1995.  By acceptance of this note, the previous note is 
considered paid in full and canceled.

The indebtedness evidenced by this note is subordinated to any and all 
indebtedness, obligations, and liabilities of BioTechnica International, 
Inc. hereof to Harris Trust and Savings Bank in the manner and to the 
extent set forth in that certain Subordination Agreement with said Bank 
dated June 29, 1994, to which reference is hereby made of a more fully 
statement thereof.

The note will be due and payable on July 1, 1998.

The interest rate for each period (July 1 through June 30 of the 
following year) will be determined annually on July 1 (or the next day 
if July 1 is not a banking day).  The rate will be the one year Banque 
Nationale de Paris LIBOR interest rate plus 7/16% p.a.

Interest will be paid annually to Limagrain Genetics Corp. on June 20 
prior to the end of each annual period.

In the event of default, BioTechnica International, Inc. agrees to pay 
all costs of collection and reasonable attorneys' fees to the extent 
permitted by law.  This note will be governed under the laws of the 
State of Illinois.

Signed under seal this 30th day of June, 1996.


BIOTECHNICA INTERNATIONAL, INC.           LIMAGRAIN GENETICS CORP.


/s/ J.C. Gouache                          /s/ E. Rougier
J.C. Gouache                              E. Rougier
President and COO                         President and CEO


Exhibit 10.30


AMENDMENT 2 TO EXHIBIT A

LIMAGRAIN INNOVATIONS SERVICE AGREEMENT



EXHIBIT A to LIMAGRAIN INNOVATIONS SERVICE AGREEMENT dated July 1, 1994, 
is executed this 1st day of July 1994, by and between SOCIETE CENTRALE 
DU GROUPE LIMAGRAIN (TO BE KNOWN AS LIMAGRAIN INNOVATIONS) and LG SEEDS, 
INC.

For the one-year period beginning on July 1, 1996, LG Seeds, Inc. agrees 
to pay a fee (the "Annual Fee") of $150,000.00 for services rendered 
under the Agreement.




								SOCIETE CENTRALE DU 
								GROUPE LIMAGRAIN (TO BE
								KNOWN AS LIMAGRAIN
LG SEEDS, INC.						INNOVATIONS)

/s/ B. CARETTE                	       By	/s/ A. CATALA
President and Chief Operating Officer      Title    Chief Executive 
Officer
July 1, 1996                               Date     July 1, 1996





Exhibit 10.32

                      AMENDMENT 2 TO EXHIBIT A

                   BIOTECHNOLOGY SERVICE AGREEMENT



EXHIBIT A to BIOTECHNOLOGY SERVICE AGREEMENT dated July 1, 1994, is 
executed this 1st day of July 1994, by and between BIOCEM S.A. and LG 
SEEDS, INC.

For the one-year period beginning on July 1, 1996, LG Seeds, Inc. agrees 
to pay a fee (the "Annual Fee") of $50,000.00 for services rendered 
under the Agreement.


 
LG SEEDS, INC.                                    BIOCEM S.A.
			
/s/ BRUNO CARETTE                                 /s/ EMMANUEL ROUGIER
    BRUNO CARETTE                       By            EMMANUEL ROUGIER
President and Chief Operating 	 Title      Chief Executive Officer
Officer
July 1, 1996                           Date       July 1, 199






Exhibit 10.34

AMENDMENT 2 TO EXHIBIT A

LIMAGRAIN GENETICS INTERNATIONAL SERVICE AGREEMENT



EXHIBIT A to LIMAGRAIN GENETICS INTERNATIONAL SERVICE AGREEMENT dated 
July 1, 1994, is executed this 1st day of July 1994, by and between 
LIMAGRAIN GENETICS INTERNATIONAL S.A. and LG SEEDS, INC.

For the one-year period beginning on July 1, 1996, LG Seeds, Inc. agrees 
to pay a fee (the "Annual Fee") of $200,000 for services rendered under 
the Agreement.



LG SEEDS, INC.					LIMAGRAIN GENETICS
							INTERNATIONAL S.A.

/s/ BRUNO CARETTE                         /s/ E. ROUGIER
President and Chief Operating Officer     Chief Executive Officer
July 1, 1996                              July 1, 1996



Exhibit 10.36


June 10, 1996

Dr. Ralph W.F. Hardy
330 The Parkway
Ithaca, NY  14850

Dear Dr. Hardy:

Pursuant to the meeting of the BioTechnica International, Inc. Board of 
Directors held in Chicago, IL on April 3, 1996, I am authorized on 
behalf of the Company to make an offer to you to repurchase all of your 
outstanding options to purchase shares of BioTechnica International, 
Inc.

According to the records of the Company you are the holder of options to 
purchase 50,000 shares of BioTechnica International, Inc. with an 
expiration date of August 29, 1999.  In exchange for these options and 
any other options which may have been issued to you, BioTechnica 
International, Inc. will pay to you the sum of $2,800.00.  This amount 
will be paid to you by check within five (5) working days of the receipt 
of your acceptance of this offer in our office in Peoria, IL.  At that 
time, we also request that you return your option grant certificate(s) 
for cancellation.

Enclosed for your information are copies of the last three annual 
reports, the Form 10K for the year ended June 30, 1995, and the three 
Form 10Qs filed for the first three quarters of the fiscal year ended 
June 30, 1996.  Should you have any questions please let me know as soon 
as possible.

If you are in agreement with these terms, please indicate by signing 
below and returning to our office in the enclosed envelope.

Very truly yours,


/s/ J.C. Gouache
J.C. Gouache
President and COO

I, Ralph W.F. Hardy, agree to sell all of my options to purchase shares 
in BioTechnica International, Inc. to BioTechnica International, Inc. 
for the sum of $2,800.00.  I waive any and all rights and privileges 
that the ownership of these options may have granted to me.


/s/ Ralph W.F. Hardy                                  June 10, 1996
Ralph W.F. Hardy                                      Dated


Exhibit 10.37


May 3, 1996

Mr. William Hittinger
52 Pippins Way 
Morristown, NJ  07960

Dear Mr. Hittinger:

Pursuant to the meeting of the BioTechnica International, Inc. Board of 
Directors held in Chicago, IL on April 3, 1996, I am authorized on 
behalf of the Company to make an offer to you to repurchase all of your 
outstanding options to purchase shares of BioTechnica International, 
Inc.

According to the records of the Company you are the holder of options to 
purchase 5,000 shares of BioTechnica International, Inc. with an 
expiration date of May 7, 2002.  In exchange for these options and any 
other options which may have been issued to you, BioTechnica 
International, Inc. will pay to you the sum of $100.00.  This amount 
will be paid to you by check within five (5) working days of the receipt 
of your acceptance of this offer in our office in Peoria, IL.  At that 
time, we also request that you return your option grant certificate(s) 
for cancellation.

Enclosed for your information are copies of the last three annual 
reports, the Form 10K for the year ended June 30, 1995, and the three 
Form 10Qs filed for the first three quarters of the fiscal year ended 
June 30, 1996.  Should you have any questions please let me know as soon 
as possible.

If you are in agreement with these terms, please indicate by signing 
below and returning to our office in the enclosed envelope.

Very truly yours,


/s/ J.C. Gouache
J.C. Gouache
President and COO

I, William Hittinger, agree to sell all of my options to purchase shares 
in BioTechnica International, Inc. to BioTechnica International, Inc. 
for the sum of $100.00.  I waive any and all rights and privileges that 
the ownership of these options may have granted to me.


/s/ William C. Hittinger                              June 10, 1996
William Hittinger                                     Dated


Exhibit 10.38


May 3, 1996

Mr. Larry D. Rieffel
4517 W.Lynnhurst Drive
Peoria, IL 61615

Dear Larry:

Pursuant to the meeting of the BioTechnica International, Inc. Board of 
Directors held in Chicago, IL on April 3, 1996, I am authorized on 
behalf of the Company to make an offer to you to repurchase all of your 
outstanding options to purchase shares of BioTechnica International, 
Inc.

According to the records of the Company you are the holder of options to 
purchase 15,000 shares of BioTechnica International, Inc. with an 
expiration date of May 17, 2003.  In exchange for these options and any 
other options which may have been issued to you, BioTechnica 
International, Inc. will pay to you the sum of $500.00.  This amount 
will be paid to you by check within five (5) working days of the receipt 
of your acceptance of this offer in our office in Peoria, IL.  At that 
time, we also request that you return your option grant certificate(s) 
for cancellation.

Enclosed for your information are copies of the last three annual 
reports, the Form 10K for the year ended June 30, 1995, and the three 
Form 10Qs filed for the first three quarters of the fiscal year ended 
June 30, 1996.  Should you have any questions please let me know as soon 
as possible.

If you are in agreement with these terms, please indicate by signing 
below and returning to our office in the enclosed envelope.

Very truly yours,


/s/ J.C. Gouache
J.C. Gouache
President and COO

I, Larry D. Rieffel, agree to sell all of my options to purchase shares 
in BioTechnica International, Inc. to BioTechnica International, Inc. 
for the sum of $500.00.  I waive any and all rights and privileges that 
the ownership of these options may have granted to me.


/s/ Larry D. Rieffel                                  June 10, 1996
Larry D. Rieffel                                      Dated


Exhibit 21

SUBSIDIARIES OF THE COMPANY
at June 30, 1996

                                                                 % Ownership

LG Seeds, Inc.                                                       100%





<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-1996
<PERIOD-END>                               JUN-30-1996
<CASH>                                             194
<SECURITIES>                                         0
<RECEIVABLES>                                     8054
<ALLOWANCES>                                        90
<INVENTORY>                                       5976
<CURRENT-ASSETS>                                 14287
<PP&E>                                           13811
<DEPRECIATION>                                    4089
<TOTAL-ASSETS>                                   32957
<CURRENT-LIABILITIES>                            13390
<BONDS>                                           3292
                                0
                                          9
<COMMON>                                          1154
<OTHER-SE>                                       14942
<TOTAL-LIABILITY-AND-EQUITY>                     32957
<SALES>                                          18767
<TOTAL-REVENUES>                                 18767
<CGS>                                            12990
<TOTAL-COSTS>                                    12990
<OTHER-EXPENSES>                                  7645
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 832
<INCOME-PRETAX>                                 (2700)
<INCOME-TAX>                                      (15)
<INCOME-CONTINUING>                             (2685)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (2685)
<EPS-PRIMARY>                                    (.03)
<EPS-DILUTED>                                    (.03)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission